Podcasts about nih

In this episode, David Watumull breaks down the science behind astaxanthin — a powerful carotenoid antioxidant backed by over 4,000 peer-reviewed papers and 100+ human clinical trials — and explains why it may be one of the most underappreciated longevity compounds available today. The conversation explores how astaxanthin anchors across cellular membranes to protect mitochondria from oxidative stress, reduce chronic inflammation ("inflammaging"), support cardiovascular health by lowering oxidized LDL and CRP, and cross the blood-brain barrier to enhance cognitive function and neuroprotection. They also discuss its role in energy production, endurance performance, healthy aging, and a landmark NIH lifespan study showing a 12% extension in mammals. Ultimately, the episode reframes longevity not as chasing stimulants or shortcuts, but as protecting cellular integrity so the body can function the way it was designed to — for longer and at a higher level. ----- 00:00 – The Longevity Molecule You've Never Heard Of 02:45 – What Is Astaxanthin? 07:30 – How It Protects Your Cell Membranes 13:40 – Free Radicals & Oxidative Stress Explained 25:50 – Brain Health, Neuroplasticity & Mitochondria 29:40 – Cardiovascular Disease & Oxidized LDL 34:05 – Alzheimer's, MCI & Neuroprotection 43:00 – Energy Production & Mitochondrial Function 58:40 – Inflammaging & Longevity Pathways 1:03:40 – NIH Study: 12% Lifespan Extension 1:09:00 – Athletic Performance & Endurance 1:15:00 – Dosing, Absorption & Bioavailability 1:26:00 – Can Antioxidants Become Harmful? 1:30:00 – Why Isn't This Mainstream? 1:37:30 – Living Ever Forward ----- Episode resources: Save 20% with checkout code EVERFORWARD at https://www.AX3.Life.com Watch and subscribe on YouTube Learn more at https://ax3.life/pages/science 

MOPs & MOEs is powered by TrainHeroic, the best coaching app on the planet. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Click here to get 14 days FREE and a consult with the coaches at TrainHeroic to help you get your coaching business rolling on TrainHeroic. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ MOPs & MOEs delivers our training through ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TrainHeroic and you can ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠get your first 7 days of training with us FREE by clicking here.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠To continue the conversation, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠join our Discord!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ We have experts standing by to answer your questions.An Instagram post a few weeks ago about how nicotine reduces bone density and slows healing no matter how it's consumed (smoking, vaping, pouches, etc.) sparked some surprisingly strong reactions. Since neither of us are experts on either nicotine's health effects or bone health in general, we knew we needed to find an expert to fill us in.Dr. Jocelyn Wittstein is a Sports Medicine Orthopaedic Surgeon and Associate Professor of Orthopaedic Surgery at Duke University specializing in the care of adolescent and adult athletes. She cares for soccer, lacrosse, and basketball teams as a team physician and consults with may regional gymnastics facilities for care of high level gymnasts. In Dr. Wittstein's clinical practice, approximately half of her focus is on adolescent and adult knee injuries, with patellofemoral stabilization being a common procedure. In addition to her clinical and research work on the patellofemoral joint, Dr. Wittstein also is a co-investigator on NIH funded studies of biomechanical and biochemical factors contributing to post-traumatic arthritis after ACL reconstruction and meniscus surgery. She is passionate about optimizing patient outcomes and safe return to sport after knee injuries.We talked to her a bit after recording about why different bios of her discuss such different work, and it's because she wears so many hats. Some things that bio missed were her particular emphasis on shoulder instability, work on the unique challenges faced by female athletes across the lifespan, and work on mitigating age related issues... It might not be clear from the broad span of research, but first and foremost she is a Full time surgeon. She was a collegiate gymnast at Cornell University, and she is a mother of five.Dr. Wittstein mentioned the app OSTEO-GAINS which helps with progressive plyometric loading will the goal of increasing bone density.

Dr Anna Maria Bombardieri is a Stanford physician-scientist working with the NIH. She is helping design the RECOVER-TLC study on stellate ganglion block for long COVID. In this mini-episode, she explains the process, who's involved in this developing study, and what the goals are.Until March 3, 2026, the study design is available to review and open to public comments. Listen to Dr Bombardieri explain the study and watch/listen to our longer video explaining everything about stellate blocks. Watch on YouTube: https://youtu.be/CcGChFTZwvY Then, be part of the science! Share your input with RECOVER-TLC: https://recovercovid.org/news/recover-tlc-seeks-input-planned-study-possible-long-covid-treatmentJoin the LCMD community for support, science, and news. Sign up at http://LongCovidMD.com#longCOVID #COVID #fatigue #MECFS #POTS #medicine #scienceSupport the showSubscribe for free written summaries of each episode, resources, and more. LongCovidMD.substack.com/subscribe Support by donating at BuyMeACoffee

MedPod Today: the podcast series where MedPage Today reporters share deeper insight into the week's biggest healthcare stories. This week, MedPage Today reporters discuss the revolving door leadership at NIH's Institutes and Centers, UnitedHealthcare's controversial new Medicare Advantage policy, and a bill that would erase two decades worth of certain types of state nursing board discipline. Episode produced and hosted by Rachael Robertson. Sound engineering by

Introducing Brain Bytes, a new micro-cast hosted by Kelly Tremblay, PhD, neuroscientist, World Health Organization advisor, NIH grant reviewer, advocate, and professor. Brain Bytes features "byte"-sized nuggets of knowledge aimed at making neuroscience accessible for the senior living world.  In each episode, which will air on the fourth Friday of each month, Dr. Tremblay will share research-backed information related to aging and brain health. This week, she explores the different types of dementia and examines what evidence-based researchtells us about it. While encouraging listeners to take practical steps to support healthy aging, Dr. Tremblay explains that a significant portion of dementia risk may be modifiable. Factors such as education, physical activity, cardiovascular health, hearing and vision care, and social connection all play a role in supporting brain health across the lifespan. The following links accompany today's episode: • https://www.nia.nih.gov/health/alzheimers-and-dementia • https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01296-0/abstract • https://www.thelancet.com/infographics-do/dementia-risk We are grateful to Parker Health for their sponsorship of this micro-cast.

Sexual medicine is underfunded, misunderstood, and often dismissed. But it's also one of the most collaborative fields in healthcare. Dr. Tami Rowen recaps this year's ISSWSH conference and what it revealed about where the field is heading.Dr. Rowen is the current president elect of ISSWSH and has been instrumental in shaping sexual medicine education and research. We recorded this right after the 2026 ISSWSH conference in Long Beach, which had almost 600 attendeesone of our biggest conferences yet.We discuss the standout research from the meeting, including award winning work on sexual function after gender-affirming hysterectomy and why most top abstracts focused on sexual pleasure rather than prevention. We talk about the reality of research funding in sexual medicine, why industry support creates conflicts of interest that look bigger than they are, and how lack of NIH funding means we have almost no treatment options for conditions like vulvodynia.We also dive into testosterone therapy why it's controversial, what the data actually shows versus what social media claims, and why Dr. Rowen doesn't treat hormone levels but rather treats individuals with specific goals. We discuss body image after breast cancer surgery, lymphedema's impact on sexual function, and why technoference is contributing to the lowest rates of sex we've ever seen.HighlightsISSWSH focuses on sexual pleasure and quality of life, not just prevention of pregnancy and STIs.Research funding for vulvodynia is $4 million annually versus $800 million for breast cancerthat's one grant versus hundreds.Testosterone therapy should treat symptoms and goals, not hormone levels or deficiencies.Body image and sexual function outcomes are significantly worse after mastectomy versus lumpectomy, even though cancer outcomes are equal.Technoference (technology interference) is contributing to historically low rates of sexual activity.If you're a clinician interested in sexual medicine, consider attending the ISSWSH Fall Course for foundational education and the annual meeting for cutting-edge research. If you're a patient navigating any issues and not currently getting help, know that there are practitioners out there who want to help you.Subscribe to the podcast and share this episode with anyone who wants to learn more about sexual medicine, menopause, or women's health education.Get in Touch with Dr. RowenWebsiteInstagramGet in Touch with Me: WebsiteInstagramYoutubeSubstackMentioned in this episode:GSM CollectiveThe GSM Collective - Chicago Boutique concierge gynecology practice Led by Dr. Sameena Rahman, specialist in sexual medicine & menopause Unrushed appointments in a beautiful, private setting Personalized care for women's health, hormones, and pelvic floor issues Multiple membership options available Ready for personalized women's healthcare? Visit our Chicago office today. GSM Collective

Dr. Jay Bhattacharya, Head of NIH and Acting CDC Director, tells about reform of a broken system, and how he's launching a vaccine injury effort. Order Sharyl's new bestselling book: “Follow the $cience.” Subscribe to my two podcasts: “The Sharyl Attkisson Podcast” and “Full Measure After Hours.” Leave a review, subscribe and share with your friends! Support independent journalism by visiting the new Sharyl Attkisson store.

Dr. Roger McFillin argues that Western allopathic medicine and psychiatry have medicalized normal human suffering by reducing emotions to biological or chemical reactions, turning symptom checklists into fixed identities, and sustaining a drug-driven "sick care" system that creates lifelong customers. He contrasts this with viewing emotions as powerful energy meant to be moved into creation and transformation, cites psychoneuroimmunology, and warns that suppressing fear and distress with pharmaceuticals can worsen long-term outcomes. The conversation covers exposure-based approaches to unlearn fear, the role of media, social media, and advertising in provoking fear and keeping people in an unconscious "drift" state, and the importance of intentional stillness, solitude (distinct from loneliness), prayer or silent meditation, and reducing phone use—especially at the start of the day—to become more conscious and intentional.    McFillin discusses how diagnostic labels like depression and anxiety shape identity, limit choices, and contribute to chronicity and polypharmacy. He contrasts PTSD with post-traumatic growth, emphasizing processing trauma memories, facing avoided situations, challenging overgeneralized threat beliefs, and practicing forgiveness and self-compassion while also taking ownership where appropriate. They also discuss the perceived harms of the "toxic masculinity" concept, men's wellbeing, the loss of wise elders, and how men often bond and cope through shared activities. Dr. Roger McFillin is a clinical psychologist and trauma recovery expert who challenges the medicalization of normal human emotions. With a focus on emotional resilience and personal growth, he specializes in exposure therapy and psychoneuroimmunology, exploring the connection between mind, emotions, and immune health. Dr. McFillin advocates for self-regulation and transforming emotional energy into healing, critiquing the overuse of pharmaceuticals in modern mental health treatment. Through his Substack, Radically Genuine, and podcast, Dr. McFillin educates individuals on overcoming fear, achieving stillness, and reconnecting with their true selves. His work empowers people to shift from a victim mindset to one of active growth, using trauma as a catalyst for resilience and positive change.   Science & Medicine   Psychoneuroimmunology   Overview & science (NIH): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130991/   Exposure Therapy   Wikipedia overview: https://en.wikipedia.org/wiki/Exposure_therapy   Cleveland Clinic explanation: https://my.clevelandclinic.org/health/treatments/25067-exposure-therapy   Anxiety & OCD exposure-based approaches (IOCDF): https://iocdf.org/about-ocd/treatment/erp/   Heart Coherence   HeartMath Institute overview: https://www.heartmath.org/heart-coherence/   Psychiatric Diagnosis & DSM   Critique of DSM and diagnostic categories: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195174/   Psychiatric diagnosis controversies: https://www.apa.org/monitor/2013/04/diagnosis   Psychology & Healing   Post-Traumatic Growth vs. PTSD   Scientific overview of post-traumatic growth: https://www.apa.org/monitor/2014/01/psychological-recovery   Journal article on PTG vs PTSD: https://www.sciencedirect.com/science/article/abs/pii/S0272735814000412   Forgiveness and Healing   Psychology Today on forgiveness: https://www.psychologytoday.com/us/basics/forgiveness   Research evidence on forgiveness and wellbeing: https://journals.sagepub.com/doi/10.1177/1745691614568356   Self‑Healing Practices   Grounding / Earthing   What is grounding/earthing? https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378297/   PEMF (Pulsed Electromagnetic Field) Therapy   Basics of PEMF therapy: https://www.health.harvard.edu/pain/pulsed-electromagnetic-field-therapy   Meditation & Stillness   Mindfulness & stillness research: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422583/   Psychology Today on solitude and healing: https://www.psychologytoday.com/us/blog/hide-and-seek/201209/finding-solitude-its-benefits-and-challenges   Cultural & Media Influence   Mind Control & Fear Provocation   The psychology of fear in media messaging: https://www.frontiersin.org/articles/10.3389/fpsyg.2020.566245/full   Media influence and persuasion research: https://www.communicationtheory.org/agenda-setting-theory/   Toxic Masculinity   Research overview on toxic masculinity: https://www.apa.org/advocacy/health-men/guidelines   What toxic masculinity means: https://www.psychologytoday.com/us/blog/the-masculine-mind/201802/what-toxic-masculinity   Dr. Roger McFillin Content   Substack (Radically Genuine): https://drmcmillan.substack.com   Show Notes 00:00 Emotions as Energy 00:33 Medicalizing Suffering 02:44 Exposure Beats Suppression 05:18 Fear and Mind Control 10:21 Stillness vs Loneliness 14:47 Simple Stillness Practices 20:12 Morning Intention Rituals 25:56 Labels and Identity Traps 31:26 Systemic Treatment Harm 32:53 Depression Label Identity 35:08 Sadness Versus Pathology 36:10 PTSD And Growth 38:24 Processing Trauma Fully 41:44 Practical Recovery Steps 45:48 Forgiveness And Ownership 50:37 Toxic Masculinity Debate 56:12 Men Friendship And Elders 01:01:05 Closing Plugs Farewell 38:24 How PTSD Develops 41:44 Practical Trauma Recovery 45:48 Forgiveness and Ownership 50:37 Toxic Masculinity Debate 56:12 Male Friendship and Elders 01:01:05 Closing and Where to Follow   The Hart2Heart podcast is hosted by family physician Dr. Michael Hart, who is dedicated to cutting through the noise and uncovering the most effective strategies for optimizing health, longevity, and peak performance. This podcast dives deep into evidence-based approaches to hormone balance, peptides, sleep optimization, nutrition, psychedelics, supplements, exercise protocols, leveraging sunlight, and de-prescribing pharmaceuticals — using medications only when absolutely necessary. Beyond health science, we explore the intersection of public health and politics, exposing how policy decisions shape our health landscape and what actionable steps people can take to reclaim control over their well-being. Guests range from out-of-the-box thinking physicians such as Dr. Casey Means (author of "Good Energy") and Dr. Roger Sehult (Medcram lectures) to public health experts such as Dr. Jay Bhattacharya (Director of the National Institutes of Health (NIH) and Dr. Marty Mckary  (Commissioner of the Food and Drug Administration (FDA) and high-profile names such as  Zuby and Mark Sisson (Primal Blueprint and Primal Kitchen). If you're ready to take control of your health and performance, this podcast is for you.We cut through the jargon and deliver practical, no-BS advice that you can implement in your daily life, empowering you to make positive changes for your well-being.   Connect with Dr. Mike Hart Instagram: @drmikehart Twitter: @drmikehart Facebook: @drmikehart

This week on the podcast, AgingIN CEO, Susan Ryan, welcomes Kelly Tremblay, PhD, a neuroscientist, World Health Organization advisor, NIH grant reviewer, advocate, and professor. As a first-generation college student, Kelly's path was shaped by lived experience. Growing up with a father who had multiple sclerosis, she became an early advocate for accessibility and healthcare equity. At the University of Washington, Kelly led research focused on the aging brain and collaborated with the National Institutes of Health and the World Health Organization to help translate science into global health strategies. In this wide-ranging conversation, Susan and Kelly discuss health literacy and Kelly's desire to bridge the gap between research and real life by making science accessible, practical, and actionable. This goal comes to life in the launch of Brain Bytes, a new monthly micro-cast debuting Friday, Feb. 27, with new episodes dropping on the fourth Friday of each month. Designed to deliver bite-sized, evidence-based insights, Brain Bytes will focus on six key areas of brain health: nutrition, hearing loss, vision loss, mood, cognition, and balance Throughout the episode, Kelly reminds us that knowledge is power—but only if it's accessible. Brain Bytes aims to empower listeners with clear, plain-language information that supports better decisions, stronger advocacy, and healthier aging.

Announcements: SOTU @5:47 Follow-ups: FDA does a 180, decides it will review Moderna's mRNA vaccine @8:51 Fetterman at SOTU @9:40 Religious Nonsense: Tennessee bill would require public schools to teach the Bible @9:45 Earlier this week, another big Texas school district said “no, thanks” @11:24 Hegseth invited pastor to lead Pentagon prayer service @12:10 State of the Union update @14:23 PRRI released a new report on Christian Nationalism @15:55 News: Armed Man Is Fatally Shot at Mar-a-Lago @18:15 Trump Considers Targeted Strike Against Iran @22:22 Jared's take on the Men's Hockey team @26:19 Ambassador Mike Huckabee suggests Israel has God-given right to Middle East @26:47 Andy Win arrested @29:41 Peter Mandelson, Ex-Ambassador to the U.S. Arrest @33:41 Politics: DoW Christian Service Draws Complaints @35:37 Ohio mayor arrested on voyeurism charges @42:34 Health/Medicine/Science: NIH Director Jay Bhattacharya the new interim director of the CDC @48:56 Uproar in MAHA because glyphosate @49:37 Skeptical Inquirer Experts warn about NIH director @57:14 U.S. Creating a brand-new parallel WHO org @57:43 Final Stories: Flavor Flav invites USA women's hockey team to 'real celebration' @58:25

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3305: Danielle Omar breaks down the essentials of omega 3 fatty acids, explaining their structure, the different types (ALA, EPA, and DHA), and why they're crucial for brain, heart, and joint health. You'll also learn which foods to prioritize and how to get enough omega 3s through simple daily choices that support overall well-being. Read along with the original article(s) here: https://foodconfidence.com/2018/11/16/everything-youve-ever-wanted-to-know-about-omega-3-fatty-acids/ Quotes to ponder: "Long story short, omega 3 fatty acids are essential polyunsaturated fats." "EPA supports your body in a ton of different ways. Getting enough EPA is super important for brain health and decreasing inflammation." "Omega 3s support heart health in some major ways! They can reduce triglycerides and blood pressure, increase HDL ('good') cholesterol, and help prevent plaque build up in your arteries." Episode references: USDA FoodData Central (Omega-3 Content of Foods): https://fdc.nal.usda.gov Recommended Daily Intake for Omega 3s (NIH): https://ods.od.nih.gov/factsheets/Omega3FattyAcids-Consumer Learn more about your ad choices. Visit megaphone.fm/adchoices

As institutions like the NIH and CDC face challenges, many professionals find themselves at a crossroads, forced to pivot their research focus to secure funding while grappling with a loss of passion and purpose. But what if there's a better way? Join Kemi as she explores pivoting versus strategic framing. Learn the difference and how to choose.  Coming soon: Applications for the Get That Grant® April 2026 cohort will open to the waitlist. Join here: www.kemidoll.com/gtgwaitlist If you'd like to learn more foundational career navigation concepts for women of color in academic medicine and public health, sign up for our KD Coaching Foundations Series: www.kemidoll.com/foundations. Text Dr. Kemi directly.

In the second installment of this three-part series, Dr. Stacey Clardy and Max Goldman discuss neuroscience research and the BRAIN Initiative.  Stay updated with everything related to Neurology on the Hill. Show transcript:  Dr. Stacey Clardy:  Hi, this is Stacey Clardy. We are going to continue with our three-part series today about the top advocacy issues covered at Neurology on the Hill 2026 in Washington, DC. Again, as many of you know, this is the AAN's annual advocacy fly-in event. Neurologists come from all over the US to Washington and meet with elected representatives to discuss issues of high importance to allow us to continue providing high-quality care to patients in the US with neurological diseases. In the first minute, we discuss the topic of Medicare, and I have with me again, Max Goldman, director of Congressional Affairs from the AAN legislative team, to talk to us about issue number two, which is neuroscience research, and specifically the BRAIN Initiative. Max, what are we going to discuss about neuroscience research? What do we need to happen in order to continue doing high-quality research? Max Goldman: So, this one is so important, and there's this wonderful program at the NIH called The BRAIN Initiative. This was founded in 2013, really reinforced in 2016 with the 21st Century Cures Act. It's just funding for basic research into how the brain works, right? And the idea behind this is that if we can understand how the brain works, we can find the next generation of treatment or cures for neurological conditions, psychiatric conditions, and issues that go through the brain. This year, we are in a precarious position. Mandatory funding for this program is expiring, and so we're going to lose a lot of money and a lot of opportunities to provide more grants to people to figure out how the brain works. So, what we are doing on Neurology on the Hill is we're asking members of Congress to support $468 million in funding in fiscal year 2027 for the BRAIN Initiative, so we can keep up the good work and keep working towards the next generation of treatments and cures for neurological conditions. Dr. Stacey Clardy: So important. Thank you, Max. To learn more about this issue and the other two issues, you can go to AAN.com. Click on advocacy. And stick with us for the third Neurology Minute, where we will get to the final issue to be discussed, telehealth. 

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3305: Danielle Omar breaks down the essentials of omega 3 fatty acids, explaining their structure, the different types (ALA, EPA, and DHA), and why they're crucial for brain, heart, and joint health. You'll also learn which foods to prioritize and how to get enough omega 3s through simple daily choices that support overall well-being. Read along with the original article(s) here: https://foodconfidence.com/2018/11/16/everything-youve-ever-wanted-to-know-about-omega-3-fatty-acids/ Quotes to ponder: "Long story short, omega 3 fatty acids are essential polyunsaturated fats." "EPA supports your body in a ton of different ways. Getting enough EPA is super important for brain health and decreasing inflammation." "Omega 3s support heart health in some major ways! They can reduce triglycerides and blood pressure, increase HDL ('good') cholesterol, and help prevent plaque build up in your arteries." Episode references: USDA FoodData Central (Omega-3 Content of Foods): https://fdc.nal.usda.gov Recommended Daily Intake for Omega 3s (NIH): https://ods.od.nih.gov/factsheets/Omega3FattyAcids-Consumer Learn more about your ad choices. Visit megaphone.fm/adchoices

Kva skjer når 150 førsteårsstudentar får ansvar for eit menneske med syns- eller bevegelsehemming dei aldri har møtt før – og skal lose dei trygt gjennom slalåmløyper, langrennsløyper og ei heile veke på fjellet? I denne episoden snakkar me om Ridderuka på Beitostølen – verdas største årlege vintersportsveke for menneske med funksjonsnedsetjing. Me snakkar også om NRK-serien Team Pølsa, som har premiere på sesong to denne veka, med tidlegare NIH-student Svein Brynhildsvoll. Han jobbar på Beitostølen helsesportsenter og er tilretteleggar for serien, og sentral både framfor og bak kamera. Kva for fagleg kompetanse og arbeid ligg bak meistringsopplevingane deltakarane i Team Pølsa får? For deltakarane på Ridderuka handlar det om meistring, identitet og aktivitetsglede. For førsteårsstudentane på NIH, som har Ridderuka som eit eige emne, er det ei erfaring mange beskriv som livsforandrande og det beste minnet frå tida på NIH. Gjestar er generalsekretær i Ridderrennet, Martin Sletten, og ergoterapeut Svein Brynhildsvoll med årsstudium i friluftsliv frå NIH – som mange nå kjenner frå den svært populære NRK-serien Team Pølsa. Kva lærer studentane som dei aldri kan lese seg til? Kvifor blir ledsagarrolla omtalt som Noregs mest undervurderte leiarutdanning? Og kva kan trenarar, leiarar og arbeidsgjevarar lære av ei veke på Beitostølen? Ein episode om tillit, ansvar, relasjonar – og det å leie utan makt. Programleiarar er Christina Gjestvang, førsteamanuensis, og Gjermund Erikstein-Midtbø, kommunikasjonsrådgjevar. Redigerar er Preben Sævartveit Henningsen.

Discover how to lose weight without Ozempic using 5 evidence-backed strategies. This episode breaks down why insulin resistance is the real driver of weight gain and how cutting processed foods, eating only when hungry, fasting, weight resistance training, and detoxification can help you lose weight naturally and sustain it long-term — no prescription required. FEATURED PRODUCT The Good Poops Protocol is designed to support the exact systems discussed in this episode — liver detoxification, gut health, and blood sugar regulation. 

The National Institutes of Health continued to lean into the use of artificial intelligence last year. The NIH has now initiated more than 100 AI pilots over the last few years. Those efforts ramped up as the health agency also navigated staffing cuts and other turmoil in 20-25. For more, Federal News Network's Justin Doubleday joins me now.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Piše Tatjana Pregl Kobe, bereta Eva Longyka Marušič in Jure Franko. Pesnik Brane Senegačnik je podkovan v teoriji poezije in njeni praksi, vešč tudi tradicionalnih oblik, zlasti soneta, a verzi njegovih mističnih pejsažev tečejo mirno valujoče kot omamno prelivajoče se skladbe: zvenijo pritajeno in se oglašajo tiho, le včasih imajo ritem karminaste trobente, barvo bledo vijoličnega jezika grozdov glicinij, hipnotično lahkotnost zlatih brez v snežni noči, kakor morska pena razlivajočih se občutkov in melodijo hlepečih sledov plohe po asfaltu, sledov tolikih življenj. Ko bolečina kot zvok božjih črk stopi s papirja v prostor pesnikove tišine, si ga v žadasti svetlobi za vselej prilasti. »Tako preprosto je to. Tako resnično.« Mistični pejsaži so nastajali v prav določenih trenutkih pesnikovega občutja, kar razkriva vsaka pesem posebej. Čeprav so pesnikovi asketsko zabeleženi zapisi nastajali v daljšem časovnem razponu, kar kažejo tudi občasne medijske objave, imajo vse v tej pesniški zbirki enak naslov Mistični pejsaži, dodana jim je le številka. Skoraj tisoč se jih je nabralo v pesnikovem predalu, za objavo v pričakovano minimalistično oblikovani knjigi – kot si jo je zamislil Lucijan Bratuš – je izbranih le sto dvajset, zadnja ima številko 981. Čeprav je bila urednica knjige Miljana Cunta, jih je verjetno izbral pesnik sam, zavedajoč se, da se pravi trenutki odvijajo v notranjem spominu, ne glede na sosledje resničnih dogodkov, ki premočrtno odtekajo v za vedno izgubljeno minulost. Za objavo vsake pesmi v knjigi čas in prostor nista bila pomembna. V spremnem besedilu Neizrekljiva svetloba Senegačnikovega jutra Milček Komelj začenja svoj dolgi poetični zapis z mislijo, da so ti mistični pejsaži resnično z mistiko prepojene pesniške krajinske slike. S svojo razlago nas kot umetnostni zgodovinar in pesnik pospremi v nežno zamišljene in poetično krhke, ritmično uglašene proste verze. Klasični filolog, prevajalec, raziskovalec grške tragedije in literarni teoretik Brane Senegačnik je v bistvu najbolj pesnik. Pesnik po duši, v zadnjih petintridesetih letih eden redkih, ki je poleg modernističnega toka zavesti v prostem verzu vstopal tudi v svet tradicionalnih pesniških oblik. Od leta 1991 do danes je izšlo devet njegovih pesniških zbirk, dve sta bili nagrajeni. Za zbirko Pogovori z nikomer (Slovenska matica, 2019) je leta 2021 prejel nagrado Prešernovega sklada, za zbirko Prosojnosti (Celjska Mohorjeva družba, 2024) pa lani Jenkovo nagrado, najvišje priznanje za poezijo Društva slovenskih pisateljev. Med sodobnimi slovenskimi pesniki je Senegačnik samohodec, lirik, v občutenju življenja prisegajoč na hipno občutje lastne biti, prisluškujoč svoji najgloblji notranjosti. Nihče v lastni poeziji ni prvi izumil odsotnosti, tišine in minljivosti, tudi Senegačnik ne, čeprav ostaja neovrgljivo dejstvo, da razmišljanje in upesnjevanje lastnih spoznanj nesporno vsakomur omogoča, da bolje razume sebe. S svojo lirsko, v vsaki zbirki bolj minimalistično izreko želi avtor s potopitvijo v globine bivanjskih izkušenj doseči popolnost. Kot vsak pravi pesnik. Življenje, ki edino stoji nasproti minevanju, postane v njegovi liriki samosvoje središče. Osredotočanje na čisto poetično postane tisto 'sem' v njegovi najgloblji notranjosti. Jezik kot izvor absolutnega, ki je v lirskem subjektu pred pisanjem, pa postane pesniška materija, ki jo mora do bistva globoko občutiti, da lahko oblikuje svoje lirične sledi. Osnovno poslanstvo Senegačnikove poezije je skozi potapljanje v tišino nenehno seganje k neizrekljivemu, včasih manj, drugič bolj odkrito. Vsak njegov verz je drobec, ki upa, da ne bo izginil v nič, a ko so skozi njegov pogled vsi tu in v določenem trenutku plameníjo nedolžnost sveta, bralca vendarle vabijo k lastni, neobremenjeni interpretaciji. V resnici gre predvsem za intimno in nežno serenado bitnosti, neločljivo povezano s svojo odsotnostjo in minljivostjo. Téma narave, ki jo Senegačnik s svetlobnimi odtenki občutij postavlja v središče različno dolgih pesmi v prejšnji zbirki Prosojnosti, je nenavadno občutljiva, krhka. Njegovi verzi v tej zbirki – enkrat abstraktni, drugič bolj figuralno določljivi – so sestavljeni z nenehnim preigravanjem z oblikami in subtilnim prehajanjem prostih verzov. Dihov besed. Pesnik je nasproti večnemu gibanju, valovanju in minljivosti bivanja postavil milino odsevov, ki presevajo njegove izpesnjene (pris)podobe. Vsaka pesem zbirke je ločen ambientalni kader, ki ga v objemu brezčasnosti hkrati navdajata izrazito čustven naboj in melanholija. Tudi v zbirki Mistični pejsaži je narava sprehajališče Senegačnikovih verzov. Samo brezgrajno občutje in odprto notranje oko zmoreta uzreti skrito življenje v čarobni paleti letnih časov in ga narediti vidnega za svet, žejen lepote. Vpliv filozofije na Senegačnikovo pesniško ustvarjanje je in je bil pomemben vse od začetka, kajti ne le brati, filozofija uči tudi razmišljati in pisati. V njegovi do kraja zreducirani minimalistični izreki bralcu ponuja slutnjo skrivnosti, iz katere smo prišli in v katero se vračamo. »Življenje je čudež, smrt modrost,« je v knjigi Štirje obrazi duše leta 2000 zapisal slikar in mislec Maksim Sedej ml., ki je vse življenje iskal modrost vsega bivajočega. Bil je prepričan, da sodobni svet ni naklonjen iskanju resnice, da beseda tehnika zabriše besedo znanost, da seksualnost zabriše besedo ljubezen. Današnji problem ni več iskanje ali najdenje, temveč sinteza najvišjega duhovnega in znanstvenega spoznanja človeštva. Zdi se, da Senegačnik v zbirki Mistični pejsaži v tem kontekstu božje umešča v neznane daljave, v nekakšno nebeško večnost in neskončnost: »Trave ti segajo do brade, / jutro preko misli // to pomeni / dotikati se zvezd s temenom / z vsemi usti svojega molčanja / peti hozána«. Božjo besedo, ki se bere vsak dan pri sveti maši kot brevir in misal. Namesto časa je nad občutljivim pesnikom nebo. Misel je v današnjem svetu navzoča in poimenovana na mnogo načinov, ima mnogo besed, izrazov, imen. Ta njena navzočnost je ključno, esencialno vprašanje. Šele z zavedanjem te navzočnosti, ko sprejme božje kot svoje bistvo, se Senegačnik kot lirski subjekt osvobaja. Šele takrat lahko popolnoma osvobodi tudi svojo misel in se zave svoje vloge v tem svetu, kajti eno je gotovo: to, kar pride na koncu, nima ne glasu ne konca. Senegačnikova poezija s svojo intimno izrazno močjo je korak k sebi in hkrati v neizogiben onkraj sebe: »Dolga smrt // v zreli julijski svetlobi, / v gosti senci akacijevih vej / tik ob neki vodi. // Nevidna kot misli. / Neizbežna / in negotova / kot je to, da si.«

If you've ever come home from what should have been a normal day and spent the next week in bed, this episode is for you. Today we're talking about post-exertional malaise, ME/CFS, long hauler fatigue, and chronic muscle pain from the perspective of someone who both treats these conditions and lives with them. Dr. Alison DiBarto Goggin walks through the full spectrum of fatigue, from normal soreness after overdoing it at the gym to the kind of debilitating exhaustion where chewing food is an effort and getting to the bathroom leaves you breathless. In this episode you'll learn what myalgic encephalomyelitis actually means and why it matters, how post-exertional malaise differs from ordinary tiredness, why this is not a deconditioning problem and why pushing harder makes it worse, what NIH-funded research is telling us about the gut microbiome and ME/CFS, what testing can and cannot tell us right now, and what a real functional medicine approach to these conditions looks like, including diet, gut health, mitochondrial support, viral protocols, and pacing strategies. This episode is for women who are tired of being told they just need more exercise, more sleep, or more willpower. There are biological reasons your body responds the way it does. There are root causes worth investigating. And there is a path forward. Resources mentioned in this episode are available at https://us.fullscript.com/plans/littleblackbagmedicine-pems and www.littleblackbagmedicine.com. To work with Dr. Alison directly, schedule online at the same link.

On this Salcedo Storm Podcast:Dr. Robert Malone, is a bioethicist who is an internationally recognized scientist in virology and immunology. He was appointed to the Advisory Committee on Immunization Practices by HHS Secretary Kennedy.

Host: Mindy McCulley, MS, Extension Specialist for Instructional Support, Family and Consumer Sciences Extension, University of Kentucky  Guests: Nathan Vanderford, PhD Director, Appalachian Career Training in Oncology Program, Markey Cancer Center, Kameron Jackson and Matthew Sanders, ACTION Program student participants Cancer Conversations Episode 72 Welcome to Cancer Conversations on Talking FACS with host Mindy McCulley. In this episode we hear from Dr. Nathan Vanderford, director of the NIH-funded ACTION (Appalachian Career Training in Oncology) program, and students Kameron Jackson and Matthew Sanders about how the program engages Eastern Kentucky high school and undergraduate students in cancer education, lab research, clinical shadowing, mentorship, and community outreach. Topics covered include student experiences in research labs and mentorship, the program's recruitment across the 54 Appalachian counties, and a unique writing project that produced four books of personal and realistic fictional stories about cancer in Eastern Kentucky. Kameron and Matthew describe how writing helped them process family history, spark conversations about cancer, and build communication skills alongside scientific training. Key takeaways: ACTION provides hands‑on research and outreach opportunities that change career trajectories, creative writing can open difficult conversations about cancer in communities, and the program aims to broaden access across the region. Find the students' stories and the full book linked in the episode show notes and visit Markey.uky.edu or the UK Markey Cancer Center Facebook page for more information. Click the images below to hear student read excerpts from Cancer in Appalachia: A Collection of Youth Told Stories   For more information about : Appalachian Career Training in Oncology Program ACTION Books Connect with the UK Markey Center Online Markey Cancer Center On Facebook @UKMarkey On Twitter @UKMarkey

Vital Mindset & Discipline PodcastFIVE PRIMARY POINTS of the PODCASTSpirituality Is Foundational to Mental Health and ResilienceThe episode argues that spirituality—defined as a belief in something bigger than oneself—is not merely philosophical but scientifically supported as a fundamental resource for promoting mental health. Peer-reviewed data cited in the podcast link spirituality and religion to improved emotional resilience, inner serenity, compassion, and psychological well-being.Religion and Spirituality Have Measurable Neurobiological and Social EffectsEngaging in spiritual or religious practices activates brain regions involved in emotional regulation and social perception. Research discussed suggests these practices strengthen social bonds, enhance compassion, reduce stress, and may improve immunity, cardiovascular outcomes, and overall longevity.Spiritual Well-Being Can Be Measured and StrengthenedA nine-question NIH survey (Experience of All Life Stressors Short Form) is presented as a concise tool to assess spiritual well-being, including purpose, peace, gratitude, compassion, presence, and connection to a higher power. The key message: we cannot eliminate suffering, but we can train ourselves to respond to it better by strengthening these dimensions.Forgiveness and Purpose Are Powerful Biological ToolsForgiveness is framed not just as a moral virtue but as a physiological stress-reduction strategy. Research on the REACH method shows forgiveness reduces anxiety and depression. Similarly, a strong sense of purpose is associated with increased longevity. Both are actionable ways to deepen spiritual vitality.Awareness of Mortality Clarifies Meaning and ActionThrough the “shovel next to the grave” reflection, the episode emphasizes that recognizing life's fragility sharpens focus on purpose, service, and compassion. Rather than being morbid, contemplating mortality helps individuals live more intentionally—working hard at work worth doing, as quoted from Teddy Roosevelt.Copyright VyVerse, LLC. All Rights Reserved. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit vitalityexplorers.substack.com/subscribe

Dr. Raymond Barnhill on Diagnostic Drift, Uncertainty, and the MPATH-Dx V2.0 Approach to Melanocytic LesionsIn this episode of The Girl Doc Survival Guide, Christine interviews Dr. Raymond Barnhill, a world-recognized dermatopathology expert known for work on diagnostically challenging melanocytic lesions, melanoma pathology references, and contributions to WHO skin tumor classification and AJCC melanoma staging. Dr. Barnhill shares career anecdotes and key communities at Yale and in Boston, collaborations with numerous melanoma leaders, and the founding of the North American Melanoma Pathology Study Group and the International Melanoma Pathology Study Group, as well as participation in the NIH-funded MPATH Study Group. The discussion focuses on overdiagnosis, underdiagnosis, and diagnostic discordance in melanocytic lesions, including evidence of diagnostic drift toward calling more lesions melanoma over time and the overlap between melanoma criteria and atypical/dysplastic nevi. He describes MPATH research, explains the revised MPATH-Dx V2.0 schema, explicitly recognizing uncertainty along a continuum rather than a strict benign/malignant threshold. He emphasizes practical diagnostic approaches including measuring lesion size (noting a 4 mm threshold associated with conventional dysplastic nevi and increasing concern at larger sizes), focusing on key architectural features (junctional nest variation/disarray and lentiginous proliferation), using nuclear size relative to keratinocyte nuclei (including a 1.5× threshold and counting atypical cells per high-power field) while accounting for site-specific pitfalls such as scalp nevi. The conversation also covers “gestalt” versus systematic review, the importance of due diligence using full clinical and morphologic information before ancillary testing, and cautions against overreliance on immunohistochemistry or molecular tests. Dr. Barnhill closes with career advice ends with a message that setbacks can be opportunities for growth.00:00 Welcome + Meet Dr. Raymond Barnhill (Dermatopathology Legend)01:51 Career Origins & Melanoma Pathology Mentors (Yale → Boston)03:59 Building Melanoma Pathology Study Groups (North American & International)05:57 Overdiagnosis, Diagnostic Drift & Why Discordance Happens09:43 Inside the MPATH Study: Measuring Interobserver & Intraobserver Agreement11:39 MPATH-Dx V2.0 Explained: Standardized Classes & Treatment Guidance13:59 Redefining “Low-Risk” Melanoma: Stringent pT1a Criteria + Embracing Uncertainty18:47 Practical Grading Tips: Lesion Size, Architecture & Nuclear Atypia Thresholds22:42 Gestalt vs Due Diligence: Avoiding Traps + Using IHC/Molecular Wisely (PRAME)28:39 Career Advice: Passion, Mentors, Community + Final Reflections

İkili Görüş'te Dr. Bahadır Çelebi, konuğu Aydın Selcen ile Münih Güvenlik Konferansı'ndan çıkan mesajları, ABD-İran gerilimindeki son gelişmeleri ve küresel siyasetin öne çıkan başlıklarını değerlendiriyor.Dk 10'da bahsedilen "62. Münih Güvenlik Konferansından Ne Sonuçlar Çıktı?" adlı yazı:https://daktilo1984.com/bultenler/dunya-gundemi-62-munih-guvenlik-konferansindan-ne-sonuclar-cikti/Yayın sonunda bahsedilen Devrim Muhafızları'nın gücüne dair Reza Talebi'nin yazısı (ENG):https://daktilo1984.com/d84intelligence/beyond-the-budget-how-irans-revolutionary-guards-built-an-economic-power-of-their-own/00:00 Giriş00:35 Galatasaray'ın Juventus'u 5-2 yenmesinin düşündürdükleri (futbol dışında her şey)09:00 Demokrasi ve hukuka tecdid-i iman10:10 2007'den bugüne Münih Güvenlik Konferansı'nın içerik değişimi12:00 Seçmeni Trump'ı Beyaz Saray'a bir nthr bom*cısı olarak gönderdi, tabir caizse17:30 İyi bir taktisyen ama kötü bir stratejist: Putin18:20 Münih Güvenlik Konferansı'nda Rubio'nun alkışlanması: Avrupa'nın trajedisi19:30 ABD Yudeo-Christian'lıktan Yudeo'yu düşürme peşinde: yeni sömürgecilik kapıda22:30 AfD Türkiye'de şubesini ne zaman açacak?26:00 Münih Güvenlik Konferansı: Düzen yıkılıyor değil, yıkıldı.27:40 Trump ara seçimde (Kasım 2026) hem Senato'yu hem Meclis'i kaybedecek gibi28:50 Sen Kübalı bir Marco Rubio'sun, Avrupa'nın çocuğuyum deme31:50 ABD'de dindarlaşma ve dinden uzaklaşma paralel olarak yoğunlaşıyor33:50 Devlet-altı aktörlerin devri kapanıyor ama mevcut çatışmalar "devlet"in azarıyla bitmez51:50 ABD, İran'la görüşmelerdeki heyecanını yeni uçak gemileri sevk ederek gösteriyor(!)01:01:01 MOSSAD'ın derin düşüncesi: İran rejimini yıkınca başa kimi koyacağız?01:04:20 Münih Güvenlik Kaonfrası'nda Mazlum Abdi vardı, Suriye Dışişleri Bakanı'nın yanında 01:07:20 Epstein dosyalarının gösterdiği: Avrupalı "beni, oy verdiğim kişi yönetmiyormuş" diye düşünüyor01:12:50 Almanya'nın silahlanması kötü. Japonya'nın silahlanması kötü. İkisinin aynı zamanda silahlanması...Ayrıcalıklardan yararlanmak için bu kanala KATIL:https://www.youtube.com/channel/UCWyDy24AfZX8ZoHFjm6sJkg/joinBizi Patreon'dan Destekleyin

ANN ARBOR —News, advice and research about what we eat - and drink - and how it influences our health is inescapable.What we hear less about is exactly what's taking place inside the body when nutrition is considered bad or toxic, say ultraprocessed foods like our favorite packaged cookies, chips or frozen pizza, or good and healthy, those whole, methyl-donor-rich leafy veggies, beefs and eggs.If you want a deeper understanding, ask Dana Dolinoy. The answers are in epigenetics, her specialty.As a nutritional and environmental scientist and professor at the School of Public Health, she studies the changes that take place in response to nutrients. Her work digs deep down to the genes and DNA, at the epigenome, where the controls that turn genes on and off are located.Dolinoy is also director of the NIH-supported Michigan Life Stage Environmental Exposures and Disease Center and Michigan Medicine's Epigenomics Core, teams that advance research and understanding of the environmental causes of chronic diseases and conditions. She is also on the team that launched MI-CARES, the Michigan Cancer and Research on the Environment Study, which is recruiting 100,000 Michigan residents to find causes of and solutions to disease. More on the study.As Dolinoy discusses in this episode of Michigan Minds, epigenetics, "is actually a relatively new science. The term was first coined in the 1950s as a way to talk about the intersections of our genes in the environment."Michigan Minds is produced by Greta Guest and hosted by Michigan News staff. Jeremy Marble is the audio engineer and Hans Anderson provides social media animations. Listen to all episodes of the podcast. Hosted on Acast. See acast.com/privacy for more information.

On the DSR Daily for Monday, we discuss the DOJ's ludicrous claims regarding the Epstein Files Transparency Act, DHS attempting to have tech companies unmask anti-ICE accounts, the vacuum of leadership at the NIH, and more.  Learn more about your ad choices. Visit megaphone.fm/adchoices

On the DSR Daily for Monday, we discuss the DOJ's ludicrous claims regarding the Epstein Files Transparency Act, DHS attempting to have tech companies unmask anti-ICE accounts, the vacuum of leadership at the NIH, and more.  Learn more about your ad choices. Visit megaphone.fm/adchoices

On the DSR Daily for Monday, we discuss the DOJ's ludicrous claims regarding the Epstein Files Transparency Act, DHS attempting to have tech companies unmask anti-ICE accounts, the vacuum of leadership at the NIH, and more.  Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of the Eye Believe Podcast, we're joined by Dr. Zack Oakey, a board-certified ophthalmologist and ocular oncologist with extensive training in retinal disease and ocular oncology.   Dr. Oakey shares his unique approach to using social media—especially TikTok—to educate patients, combat misinformation, and make complex ocular melanoma topics more accessible. Drawing from his training at institutions including the NIH, UC Irvine, the University of Wisconsin, and the Cleveland Clinic's Cole Eye Institute, he offers valuable insight into how trusted medical information can reach patients where they already are.   This episode blends medical expertise with modern communication, offering both reassurance and actionable information for patients, caregivers, and advocates alike.   Tune in to hear how education, accessibility, and innovation can make a real difference in the OM community.

Nessa live, eu conversei com o biomédico e pesquisador Dr. Andrew Koutnik (@andrewkoutnikphd)Dr. Andrew Koutnik é um cientista cuja carreira integra ciência de ponta, performance de elite e experiência pessoal vivendo com diabetes tipo 1 há mais de 17 anos. Doutor em Ciências Médicas (Farmacologia e Fisiologia Molecular) pela University of South Florida, ele desenvolveu pesquisas financiadas por instituições como NASA, Departamento de Defesa dos EUA e NIH, acumulando mais de 100 publicações e apresentações científicas internacionais. Seu trabalho investiga como nutrição, metabolismo e estilo de vida podem otimizar saúde, desempenho e resiliência — tanto em doenças crônicas quanto em contextos de alta exigência física.Atualmente professor no Institute for Sports Science and Medicine da Florida State University, Dr. Koutnik lidera estudos sobre fisiologia do exercício, saúde cardiometabólica e nutrição terapêutica, incluindo estratégias dietéticas para diabetes tipo 1 e 2, obesidade, sono e performance sob estresse metabólico. Colabora com instituições como Harvard Medical School e Boston Children's Hospital. Sua missão central é promover saúde metabólica baseada em evidência, ajudando indivíduos — inclusive atletas de elite — a alcançarem alto desempenho mesmo diante de desafios crônicos. Fora do laboratório, dedica-se à família e à prática de Brazilian Jiu Jitsu e treinamento físico.No Clube de Leitura, exploramos juntos obras que desafiam o senso comum — livros que unem ciência, filosofia e ancestralidade — sempre com uma visão crítica e prática para transformar o conhecimento em ação.

This episode covers: • Mic-628 Could Reset Your Body Clock and Cut Jet Lag in Half A new circadian drug candidate, Mic-628, has demonstrated the ability to shift the body's internal clock and significantly reduce jet-lag recovery time in early human studies. In controlled simulations, participants experienced faster realignment of their sleep-wake cycles and improved daytime performance compared to standard approaches like melatonin and light timing alone. Dave explains how this compound targets a core clock pathway, why eastbound travel is biologically harder than westbound, and how pharmacologic chronotherapy could become a serious performance tool for frequent travelers and shift workers. He also connects circadian alignment to obesity, insulin resistance, cardiovascular risk, and cognitive decline, outlining what this breakthrough could mean if safety data continues to hold. • Source: https://www.sciencedaily.com/news/top/ • Late-Life Depression May Signal Parkinson's or Dementia New research from Shanghai Jiao Tong University found that new-onset depression in older adults is strongly associated with increased risk of Parkinson's disease and dementia. Dave reframes this finding as a brain health signal rather than a purely psychiatric issue, explaining how inflammation, microglial activation, vascular health, and neurodegeneration intersect with mood changes. He breaks down why sudden depression in someone with no prior history may warrant deeper cognitive testing, sleep evaluation, and metabolic screening instead of simply prescribing an antidepressant and moving on. This story highlights the importance of treating mood shifts as early biological data in a longevity framework. • Source: https://www.sciencedaily.com/releases/2026/02/260210040623.htm • Speed-Training Brain Games Reduced Dementia Risk by 25 Percent The long-running NIH-funded ACTIVE trial found that a specific speed-of-processing training program reduced dementia incidence by roughly 25 percent over two decades. Unlike memory or reasoning exercises, this visual processing speed protocol produced measurable long-term protection. Dave explains why reaction time and processing speed may be core capacities tied to cognitive resilience, and how structured brain-training programs descended from this research can be treated like strength training for the mind. Instead of vague advice to “stay mentally active,” this data supports building deliberate, trackable cognitive training into a midlife longevity plan. • Sources: – NPR summary: https://www.npr.org/2026/02/09/nx-s1-5702423/modest-mental-exercise-can-reduce-risk-of-dementia-for-decades-study-finds – Psychology Today analysis: https://www.psychologytoday.com/us/blog/build-your-brain/202602/new-study-means-the-age-of-dementia-prevention-begins-now • Moderate Coffee Intake Linked to Slower Brain Aging A large analysis of roughly 130,000 participants found that moderate coffee consumption, about one to three cups daily, was associated with markers of slower brain aging and lower dementia risk. Dave explains why moderate, morning-weighted caffeine intake may align acute performance benefits with potential long-term brain protection. He breaks down the dose curve, why more is not necessarily better, and how to use coffee strategically without compromising sleep or circadian rhythm. Rather than framing caffeine as either a miracle or a villain, this study supports intelligent, personalized dosing as part of a broader brain-health stack. • Source: https://www.nature.com/articles/d41586-026-00409-y • Kratom Crackdowns and the Future of Supplement Freedom Regulators are tightening restrictions on high-potency kratom derivatives such as 7-hydroxymitragynine, with new bans and stricter warning requirements emerging at the state level. The FDA continues to treat kratom and its concentrated derivatives as unapproved drugs with opioid-like effects, while local jurisdictions are targeting specific formulations linked to adverse events. Dave breaks down how this represents a broader shift in how edge-case compounds are regulated, why supply volatility and underground markets can increase risk, and what this means for biohackers who experiment with gray-area tools. He also explains how evolving enforcement strategies could shape future access to peptides, nootropics, and other advanced compounds. • Sources: – Kansas City coverage: https://www.kshb.com/news/local-news/strong-high-weak-laws-7-oh-ban-kratom-regulation-moves-forward-in-kansas-city-missouri – Florida policy coverage: https://www.wgcu.org/health/2026-02-04/kratom-advocates-tout-its-properties-but-legislators-want-strict-warnings-about-the-herbal-supplement – Legal landscape analysis: https://www.lumalexlaw.com/2025/10/09/kratoms-legal-future-how-states-and-the-federal-government-are-responding/ – FDA background: https://www.fda.gov/news-events/public-health-focus/fda-and-kratom All source links are provided for direct access to the original reporting and research. This episode is designed for biohackers, longevity seekers, and high-performance listeners who want mechanism-level clarity on circadian biology, neurodegeneration signals, cognitive training, caffeine strategy, and supplement regulation. Host Dave Asprey connects emerging science, behavioral data, and policy shifts into practical frameworks you can use to build a resilient, adaptable health stack. New episodes every Tuesday, Thursday, Friday, and Sunday. Keywords: Mic-628 circadian drug, jet lag recovery science, chronotherapy biohacking, late life depression dementia risk, Parkinson's prodromal symptoms, ACTIVE trial dementia prevention, speed of processing training, brain aging coffee study, moderate caffeine longevity, kratom regulation 7-OH, supplement law biohacking, neurodegeneration early signals, cognitive performance training, circadian rhythm optimization, metabolic brain health, biohacking news Thank you to our sponsors! - Antarctica Trip | Join me in Antarctica from March 8–17, 2026. Visit https://www.insiderexpeditions.com/future and use code DAVE for $1,000 off.- TRU KAVA | Go to https://trukava.com/ and use code DAVE10 for 10% off.Resources: • Get My 2026 Biohacking Trends Report: https://daveasprey.com/2026-biohacking-trends-report/ • Dave Asprey's Latest News | Go to https://daveasprey.com/ to join Inside Track today. • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Join My Substack (Live Access To Podcast Recordings): https://substack.daveasprey.com/ • Upgrade Labs: https://upgradelabs.com Timestamps: 0:00 - Introduction 0:18 - Story #1: Circadian Drug for Jet Lag 2:00 - Story #2: Depression as Early Warning Sign 3:30 - Story #3: Brain Processing Speed Training 4:56 - Story #4: Coffee and Brain Health 6:24 - Story #5: Kratom Regulation 8:21 - Weekly Roundup 9:25 - Closing See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Is low-carb better than low-fat? Should you be eating 120 grams of protein a day? The internet says yes, but the science says it's not that simple. In this episode, Dr. Lisa Oldson digs into Dr. Kevin Hall's groundbreaking NIH research to explain why your macro ratio matters far less than you think. The real key to weight loss? The quality of the food on your plate; not the ratio of macros in it. Plus, Dr. Lisa shares why she's never counted her own macros, what to know if you're on a GLP-1 medication, and how to find your NBA, your next best action, without overhauling your entire life.Thanks for listening! If you'd like more support during your SMART weight loss & health focused journey, sign up for our FREE newsletter, or check out our program at: www.SmartWeightLossCoaching.com. We would love to help you reach your happy weight, and transform the way you talk to yourself about your body and the number on the scale. Negative thoughts about yourself don't have to take up so much brain space, and we'd be honored to help you reframe those thoughts. Also…We'd be grateful if you'd follow us and share our podcast with your friends & family. We're here to help you improve your health, live longer, healthier, and lose weight the SMART way! This episode was produced by The Podcast Teacher: www.ThePodcastTeacher.com.

Disclosures:Dr. Creech has disclosures of grant funding from NIH, CDC, Moderna, Pfizer and has been a consultant for Merck, Sanofi Paseur, TD. Cowen. Guidepoint Global, GSK, Delbiopharm, Dianthus, AstraZenecka and receives royalties from UpToDateWebsites:Philadelphia Children's Hospital Vaccine Education & ResourcesVUMC Children's Immunization GuideAAPRecommended Books:Anxious Generation: How The Great Rewiring of Childhood Is Causing an Epidemic of Mental Illness, Jonathan HaidtRighteous Mind: Why Good People Are Divided by Politics and Religion, Jonathan HaidtKey TakeawaysRSV prevention now includes both maternal vaccination during third trimester and monoclonal antibodies for infants, both showing 60-80% reduction in hospitalizationsHepatitis B vaccine is fundamentally a cancer prevention tool, and the birth dose is recommended at population level to prevent missed cases even when individual risk appears lowCocooning newborns through family immunization for influenza, pertussis, RSV, and measles is critical as community vaccination rates declineEffective vaccine conversations require avoiding shame and blame, expressing intellectual humility, asking "why" to understand concerns, and providing trusted resources rather than just educationThe future of vaccine development includes improved flu vaccines requiring less frequent administration, alternative delivery methods (intranasal, oral, microneedles), and advanced tools to understand rare adverse eventsWhile vaccine-preventable diseases like measles are increasing in pockets of under-vaccinated communities, maintaining high vaccination rates is essential to prevent widespread outbreaks of highly contagious diseasesParents face significant peer pressure around vaccine decisions, and healthcare providers should acknowledge this while modeling respectful dialogue with those who disagreeQuotable Moments"What is hepatitis B vaccine? It's a cancer prevention vaccine period. It prevents liver cancer. Why would I not want a cancer preventing vaccine?""An ounce of prevention is worth a pound of cure rather than knowing how to treat meningitis really effectively. Wouldn't it be great if we could prevent it all together?""I think we need to recognize that we probably want the same thing, except in extraordinarily weird situations. We both want the health of that child.""I recognize that there is still much to learn about these things, but here's where I land.""Vaccines and your baby's health, that's just more complicated than 140 characters.""Measles is the second most contagious virus on the planet behind smallpox, which is eradicated. So it's the first most...

Research years. Professional development time. Career exploration.Whatever you call it, stepping out of clinical residency can feel confusing, intimidating, and oddly hard to plan for. In this episode of Behind the Knife, our BTK Surgical Education Fellows Drs. Elizabeth Maginot, Nicole Petcka, Agnes Premkumar, Kara Button, Emma Burke, and Michelle LaBella sit down with Dr. Daniel Nussbaum, Associate Professor of Surgery at Duke University and leader in the Duke Residency Research Fellowship Program, to unpack dedicated resident profressional development time really looks like, who it helps, who it doesn't, and how to make the most of it if you choose to step out of clinical training.Together, the group tackles:·       Why “research years” are often better thought of as professional development time·       Whether taking time out of residency is actually necessary for fellowship or an academic career·       How to find the right mentor—and why there's rarely a “perfect” project·       Practical advice on setting boundaries, saying yes (and no), and managing unstructured time·       A clear, resident-level overview of funding options, including:- NIH T32 and F32 grants- NIH Loan Repayment Program (LRP)- Society, foundation, and departmental funding·       What faculty and program leadership look for when supporting resident research·       Lessons the panel wishes they'd known before starting research timeWhether you're a medical student curious about residency structure, a resident debating whether to step out, or faculty mentoring trainees through career development, this episode offers candid insight, real examples, and reassurance that there's more than one “right” path. High-Yield Takeaway: You don't need research time to be a great surgeon—but if you want to grow skills outside the OR, this may be the rare window to do it thoughtfully (and even enjoy it).Resources & Links Mentioned:NIH Funding & Training Programs·       NIH RePORTER – Explore active NIH-funded grants and training programs https://reporter.nih.gov/#/·       NIH T32 Institutional Training Grants https://grants.nih.gov/funding/activity-codes/T32·       NIH F32 Individual Postdoctoral Fellowshiphttps://grants.nih.gov/funding/activity-codes/F32·       NIH Loan Repayment Program (LRP) https://grants.nih.gov/funding/funding-categories/lrp·        Foundational & Society Grants(Not a comprehensive list; examples discussed in the episode)·       Association of Program Directors in Surgery (APDS) Job Board https://apds.careerwebsite.com/jobs/? ·       American College of Surgeons (ACS) – Resident research funding https://www.facs.org/for-medical-professionals/professional-growth-and-wellness/scholarships-fellowships-and-awards/resident/resident-research/·       Association for Academic Surgery (AAS) – Resident research funding primer https://www.aasurg.org/resident-research-funding-primer/·       American Surgical Association (ASA) – Research awards & fellowships https://americansurgical.org/awards_Fellowship.cgi·       Society of University Surgeons (SUS) – Resident Research Scholar Awards https://www.susweb.org/resident-scholar-research-awards/? ·       American Association for the Surgery of Trauma (AAST) – Scholarships & grants https://www.aast.org/professional-development/scholarships.html·       Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) – Research grants https://www.sages.org/research/research-grants/ Helpful Application Resources·       NIH Biosketch Format & Instructions https://grants.nih.gov/grants-process/write-application/forms-directory/biosketch Sponsor Link: Medical Education master's program at the University of Pennsylvania Graduate School of Education - https://www.gse.upenn.edu/btkPlease visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Can I Moderate? Why This Question Matters More Than We Talk About For most of my recovery journey, I held a pretty firm belief: If you're questioning your drinking, the answer is probably abstinence. That belief came from both lived experience, as well as observing other people who struggle with alcohol. Personally, I never drank normally. From the very first drink, the switch flipped on—and it stayed on. I hit a hard bottom early, and after years of trying to moderate, the answer for me was clear: I could not moderate. As it turned out, for me abstinence meant freedom. And still… Over time, something softened in me. Not because I changed my relationship with alcohol—but because I started listening more closely to other people's experiences. The Question Everyone Has to Answer for Themselves I've come to believe this: "Can I moderate?" is not a denial question. It's a developmental one. For many people, it's the pivot point of their entire recovery journey. Some people answer it quickly. Some answer it painfully. Some don't answer it until years—sometimes decades—later. But skipping the question doesn't make it disappear. And that's why my conversation with Nick Allen, CEO and co-founder of Sunnyside, felt so important. Nick grew up in an AA household. Both of his parents are in long-term recovery. He understands abstinence deeply—and still, his own relationship with alcohol took a different path. Instead of waiting for a crisis, he began asking a quieter question early on: What does a healthy relationship with alcohol look like for me—right now? That question eventually became Sunnyside: a platform designed to help people explore change before things fall apart. The Missing Middle Here's the reality I see again and again: Most people are offered two options: Figure it out Quit forever And when those are the only choices on the table, a huge number of people choose to keep trying to figure it out. Not because they're reckless. Not because they don't care. But because abstinence can feel overwhelming, stigmatizing, or premature—especially for people who are still functioning "well enough." Research suggests there's often a 10-year gap between when alcohol becomes a problem and when someone seeks help. Ten years. Think about what happens in ten years: Careers strained Health eroded Relationships damaged Kids absorbing instability they can't name yet Waiting is not neutral. Why Willpower Isn't the Answer One thing Nick and I aligned on immediately: Willpower is a terrible long-term strategy. Willpower is finite. It's lowest at the exact moments people need it most: After a long day During stress At the witching hour (5–7pm) On Fridays when it's "been a week" Sunnyside takes a different approach: Decisions are made ahead of time, when clarity is high Habits are supported with structure, not shame Accountability is externalized, not moralized This is how real behavior change works. A Word About Naltrexone (And Nuance) We also talked openly about naltrexone, a medication that's been FDA-approved for decades to help reduce alcohol cravings. Here's what matters: It doesn't make people sick It doesn't require abstinence It reduces the reward loop that drives compulsive drinking I've had clients use it successfully—particularly high-functioning people who struggled with the "off switch," not daily drinking. But for people earlier in the process—people quietly wondering, "Is this still working for me?"—tools like this can interrupt years of silent suffering. Language Matters More Than We Think One of the most powerful parts of this conversation was about vocabulary. Words like addict, alcoholic, relapse, recovery—they carry weight. For some people, they offer clarity and belonging. For others, they create shame, fear, and avoidance. If the language feels too heavy, people wait. Sunnyside intentionally avoids labels and instead talks about: Alcohol overuse Habit change Awareness Experimentation That shift alone can make change feel possible. Where I Land Now I'm still sober and have no desire to drink again. I still believe abstinence is the right path for most people who struggle with alcohol. And I also believe we need earlier, gentler, more honest entry points into change. The goal of sobriety—or moderation, or reduction—isn't the absence of alcohol. It's: Freedom Health Presence A life that actually works If someone can get there sooner, with less damage along the way, I'm all for it.     Action Steps If this resonated, here are a few grounded next steps: Ask the question honestly Is alcohol adding to my life—or quietly taking from it? Move from judgment to curiosity You don't need a label to run an experiment. Plan ahead of cravings Decisions made in advance beat willpower every time. Seek support early Coaching, tracking, community, and medical tools are preventative—not last resorts. Protect what already works If abstinence is serving you, honor that. No need to second-guess stability.     Resources Sunnyside: https://www.sunnyside.co/arlina Sunnyside Med (Naltrexone access) NIH research on alcohol use disorder and treatment gaps AA and abstinence-based recovery programs (for those who already know)     If you're listening to this podcast, reading this post, or even asking the question quietly to yourself—you're already earlier than most. And earlier matters.   Guest Contact Info: https://get.sunnyside.co/arlina

In this episode of Office Hours, Dr. Carlton J. Fong, educational psychologist and faculty member in the Department of Curriculum & Instruction at Texas State University, shares how his journey from studying cognitive science at UC Berkeley to earning his Ph.D. in Educational Psychology at UT Austin shaped his passion for understanding how students learn, stay motivated, and succeed. He reflects on his own college experiences, the mentors who helped guide his path, and the personal moments that pushed him toward researching student motivation and belonging.Dr. Fong also dives into his work on self-regulation, help-seeking, and student agency, including what his research reveals about what actually helps students thrive in college. He discusses his NIH-funded project in STEM education, the importance of empowering students to take ownership of their learning, and why feeling like you belong can make all the difference. His story offers a thoughtful look at mentorship, research with real-world impact, and how understanding yourself as a learner can change your entire college experience.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a series of transformative events shaping the landscape of drug development, regulatory scrutiny, and corporate strategies.At the forefront is Madrigal Pharmaceuticals' strategic acquisition of Ribo Therapeutics' preclinical siRNA programs, valued at $4.4 billion. This move aims to fortify Madrigal's liver disease drug portfolio alongside its promising candidate, resmetirom. By expanding into RNA-based therapies, Madrigal highlights an industry trend focused on gene silencing techniques to target genetic diseases more precisely.Turning to Moderna, it faces a regulatory hurdle as the FDA issued a refusal-to-file letter for its mRNA-based flu vaccine. The regulator's concerns about the trial design, specifically the use of a licensed standard-dose seasonal influenza vaccine as a control arm, emphasize the complexities of advancing mRNA technologies beyond COVID-19 applications. This situation underscores the necessity for meticulous trial designs that align with evolving regulatory standards.In cell therapy, allogeneic CAR-T treatments are gaining attention as companies strive to make these therapies more accessible by using T cells from healthy donors, rather than modifying a patient's cells. Despite technical challenges like graft-versus-host disease and immune rejection, these treatments promise streamlined manufacturing and reduced costs, marking a significant evolution from the pioneering autologous CAR-T success with Emily Whitehead in 2012. Eli Lilly's entry into CAR T-cell therapy through a $2.4 billion acquisition of Orna represents an ambitious expansion into autoimmune therapies. This strategic move exemplifies a broader trend where companies diversify portfolios to include emerging therapeutic modalities promising transformative impacts on patient care.In respiratory medicine, Upstream Bio's phase 2 trial of its TSLP receptor agonist showed encouraging results in reducing asthma exacerbations, comparable to Tezspire. However, falling short of best-case scenarios leaves room for competitors to present more compelling data. This illustrates the competitive nature of asthma treatment development and the ongoing quest for superior therapeutic options.A critical regulatory update arises from the NIH's decision to halt the Xarelto arm of a stroke prevention trial due to safety concerns. This decision highlights the indispensable role of independent monitoring committees in ensuring patient safety and meaningful clinical trial outcomes.On the corporate front, AstraZeneca has articulated an ambitious goal to achieve over 25 blockbuster drugs by 2030 as part of its strategy to reach $80 billion in revenue. This vision underscores the importance of innovation and strategic planning in sustaining growth within an increasingly competitive market.Fujifilm Biotechnologies' completion of its £400 million expansion project in the UK is another notable development, signaling robust investment in antibody production capabilities. This expansion positions Fujifilm as a key player in biopharmaceutical contract manufacturing and underscores the growing demand for flexible production technologies.The biotech sector is also witnessing significant activity with Pelage making strides in addressing hair loss through promising candidate developments. The market's enthusiasm for innovative solutions beyond traditional treatments reflects a broader demand for cutting-edge approaches to longstanding medical challenges.In obesity treatment, Novo Nordisk and Eli Lilly continue to lead with notable advancements. Novo Nordisk's recent developments with its Wegovy pill have been positively received, yet analysts question if this will suffice in maintaining their competitive edge given the dynamic nature of this therapeutic areSupport the show

It's been three full years since the Ohio state government decided to detonate derailed train cars containing vinyl chloride in the village of East Palestine.You might remember the apocalyptic imagery that came out of that explosion—it looked like a nuclear bomb had gone off.Three years later, anecdotal evidence is showing that the residents are experiencing thyroid disease, cancers, respiratory problems, neurological issues, asthma, and other problems.The National Institutes of Health (NIH) has now announced a $10 million research project to study the long-term health effects on the people living there.Let's review what took place there in 2023, what the effects appear to be now, as well as what the NIH is doing about it.

In this no-holds-barred interview, Dr. Jay Bhattacharya, director of the National Institutes of Health, breaks down how the world's largest public funder of biomedical research is changing under his leadership.Bhattacharya, a former professor of Stanford University, public health expert, and coauthor of the anti-lockdown Great Barrington Declaration, was sworn in as director of the NIH in April last year.With an annual budget of almost $50 billion, the NIH sets the direction of research at universities, medical centers, and research institutes across America.It encompasses 27 institutes and centers that cover different areas of health and employ some 20,000 people. One of those is the National Institute of Allergy and Infectious Diseases, which was headed by Dr. Anthony Fauci for nearly 40 years.The NIH, Bhattacharya told me, “really hasn't had a change in leadership in decades. ... We've had new directors, but the fundamental structure and direction of the NIH has been basically the same until last year.”Bhattacharya says his top priority is to end the practice of “funding the scientific enterprise for the sake of funding science” and ensure that NIH-funded scientific research actually produces better health outcomes for the American people. The goal should be improvements in health and longevity, not just more scientific papers, he says.During our interview, we covered a lot of ground, including:-Has the NIH completely stopped funding gain-of-function research?-Is the NIH continuing to fund research with China?-How has funding for international research institutes been restructured?-Has the NIH stopped funding all research grants related to diversity, equity, and inclusion initiatives?-What is being done to reverse the politicization of science?-What is the NIH doing to help those who suffered injuries from the mandated COVID-19 mRNA vaccines?-What can the NIH do to alleviate the massive replication crisis in research?-How does he view the controversy surrounding vaccines and autism? Is the NIH looking into potential links?-How is the NIH restructuring the allocation of funding?What America needs, Bhattacharya told me, is a “second scientific revolution,” saying: “The NIH has the capacity to induce that second scientific revolution. That's what I'm going to work toward for the next few years.”Views expressed in this video are opinions of the host and the guest, and do not necessarily reflect the views of The Epoch Times.

News: ‘Made me feel proudly American': stars react to Bad Bunny's Super Bowl show @2:34 ‘Penisgate' at the Olympics @11:13 Epstein met with 4chan's founder just as the site's infamous political thread began @16:45 Health/Medicine/Science: CFI's OPP issued a nationwide Action Alert @32:29 RFK Jr. putting facilitated communication on HHS autism panel @35:10 “Kennedy Makes Unfounded Claim @36:48 Who‘s Really Behind the MAHA Movement? @38:02 Dr. Oz was on CNN attempting to rewrite history in real-time. @39:34 More measle vaccines @42:04 SC senator proposes mandatory measles vaccines for students @43:04 But Iowa learns nothing @43:45 “NIH director says he hasn't seen evidence that vaccines cause autism.” @45:11 Newborn dies after mother drinks raw milk during pregnancy @45:31 Religious Nonsense: CFI's (OPP) submitted written testimony opposing SB 1025 @48:07 Missouri Beacon reports on a new bundle of legislative proposals @48:57 Wrapping up, Olympics talk @50:08 Grand jury refuses to indict Democratic lawmakers @57:17

CEREMONIAL SCI OP - 02.09.2026 - #914 BestPodcastintheMetaverse.com Canary Cry News Talk #914 - 02.09.2026 - Recorded Live to 1s and 0s Deconstructing World Events from a Biblical Worldview Declaring Jesus as Lord amidst the Fifth Generation War! CageRattlerCoffee.com SD/TC email Ike for a discount https://CanaryCry.Support   Send address and shirt size updates to canarycrysupplydrop@gmail.com Join the Canary Cry Roundtable This Episode was Produced By:   Executive Producers Michael B*** Sir LX Protocol Baron of the Berrean Protocol***   Producers of TREASURE (CanaryCry.Support) Cage Rattler Coffee   Producers of TIME Timestampers: Jade Bouncerson, Morgan E Clankoniphius Links: JAM   SUPPLY DROP Calendar and Goldback bonus to new sign ups   OLYMPICS DEVIL 2:48 Ring "Search party"  Clip: Olympics Pentagram Clip: Spiral imagery at opening ceremony (X) Clip: Israeli's boo'd at opening ceremony, walking through Stargate (X) Clip: Israel boo'd? (X)  Israeli Bobsled team Robbed (Fox) → Clip: Milan protests are intense → Clip: more protest footage AP gives no reason for riots at Olympics (AP) → DHS post, sent ICE agents to Italy for Olympics, quotes Variety (X)  Suspected saboteurs hit Italian rail network near Bologna, police say (CBC)   EPSTEIN 1:33:28 Note: France former culture minister resigns over Epstein (AP) Cclip: Ro Khana on the destruction of the royal family (cnn)  'Evil': Conservatives ERUPT on Steve Bannon Over Epstein Revelations (MediaIte) Epic Games denies rumors about presence of Jeffrey Epstein alive and playing Fortnite (MSN) Epstein heavily involved in "Micro-transactions" in video games Epstein WoW account and money laundering (IBT)   -Epstein Reportedly Ordered Multiple 55-Gallon Sulfuric Acid in 2018: 'Likely Used to Dissolve Bodies of Children' (IBT) → 330-Gallon Sulfuric Acid Purchase in 2018 Sparks Speculation (Criminal Watch) → He ordered 6x55 gallons which = 330 (X)   SCIENCE IS TRUTH 2:26:33 1-CRISPR removes chromosome to cure Down syndrome (Time of India) → Innovative Approach Developed for Removing Extra Chromosome 21 in Cells from Individuals with Down Syndrome Using CRISPR-Cas9 Genome Editing Technology (MIE) 2-First human trials of locally-developed HIV jab begin in South Africa (Yahoo/Telegraph) 3-Mexican Researchers Breakthrough That Could Lead to Complete Elimination of HPV (I24)   CANCER 2:30:55 4-Spanish scientists cure pancreatic cancer in mice in medical breakthrough (Fox) 5-Korean Scientists Reversed Colon Cancer Cells to Normal State (Open Gate Media) 6-Precision conversion of colorectal cancer lung metastases (NIH) 7-Russia unveils first test batches of cancer vaccine (RT) 8-Scientists discover 'levitating' time crystals that you can hold in your hand (Phys.org) 9-New type of magnetism discovered in 2D materials (Phys.org) Clip: Uncles Tremble as Man Invents Vaccine Delivered by Beer (Futurism)   GATES OF THE GODS/SPACE 2:39:29 *Scientists Say Heck, Just Nuke a Killer Asteroid Heading for Earth (Futurism)   EXECUTIVE PRODUCERS 2:47:57 TALENT/TIME 3:00:25 END 3:12:08

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: T1D in the Olympics & Superbowl, Trump RX goes live, Ozempic pill available soon, tech updates from Medtronic, Beta Bionics, Eversense 365 and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  T1D Screening info All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcription with links: Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bringing you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. Quick reminder: We are just over one week from our first Moms' Night Out event of the year. While the plans are all set – the speakers, the vendors, the raffles and the fun is ready to go, it's always amazing how many people hear of these event last minute. That's fine, they're welcome! But if you're thinking of attending a future event – registration is open for We're going to Nashville next March 6-7 and Detroit in September – no need to wait. And we've got Club 1921 events for health care professionals and patient leaders in 6 cities this year! All the info is over at diabetes-connetionss.com events/   Okay.. our top story this week: XX Gotta be a quick shout out to some incredible T1D athletes – we had TWO in the super bowl this past weekend – Chad Muma of the New England Patriots and Logan Brown of the Seattle Seahawks AND there are at least two athletes with type 1 competing at the Winter Olympics. Hannah Schmidt competes in ski cross for Canada – she was diagnosed with Type 1 diabetes at age 12 years old.  Anna FarnSchadt Fernstäd a Czech skeleton racer diagnosed in 2022 after she'd already been to several Olympics. We wish them all the best!   https://english.radio.cz/skeleton-racer-anna-fernstadtova-overcoming-adversity-headfirst-down-ice-8876699 XX The government website TrumpRx.gov is live..  the website does not sell prescription drugs. Instead, it allows people to look up their drugs and then navigate to buy them elsewhere, either from a major drug company or a pharmacy. The 43 drugs listed on the site have prices ranging from $3 to over $5,500. TrumpRx does include warnings that the site may not be the best option to save money on prescriptions. Each product page advises: "If you have insurance, check your co-pay first — it may be even lower." For now, the website says its prices are for people paying with their own money, rather than going through insurance. The only insulin listed right now is Lilly's insulin lispro – and it's the same price as you'd find through Illy's insulin value program. I looked up diabetes meds.. For example, if you have an insurance co-pay of $25 a month for Farxiga, a drug often used for diabetes, you would be paying $182 on TrumpRx. As you can imagine, though ,this is complicated and as with most of our healthcare system, it may be good in some cases and not much help in other.  I'd suggest calling your local pharmacist or checking with your human resource dept. https://www.nytimes.com/2026/02/06/health/trumprx-prescription-drug-prices-consumers.html XX Novo Nordisk will launch some doses of its oral semaglutide for diabetes under the brand name Ozempic pill in the second quarter of this year. The company said the U.S. Food and Drug Administration has approved Ozempic tablets in three different doses. Novo says The new Ozempic name is intended to help patients and health care professionals more easily recognize the available treatment options for type 2 diabetes Semaglutide tablets have been available under the brand name Rybelsus Ruh BELL sis for diabetes since 2019 but with different dosing. The pill is also approved to reduce the risk of certain cardiovascular conditions in adults with type 2 diabetes who are at high risk for these events. The FDA had approved the new doses based on a bioequivalence study and the clinical trial data for Rybelsus, Novo said. https://www.reuters.com/business/healthcare-pharmaceuticals/novo-launch-ozempic-pill-diabetes-second-quarter-this-year-2026-02-04/ XX https://www.contemporarypediatrics.com/view/early-screening-for-type-1-diabetes-found-effective-in-children XX Possible new way to identify and track the progress of type 1 diabetes before clinical onset. A recent study published in Science Advances described the application of subcutaneous microporous scaffolds. These are inserted and have been shown to  identify changes in cancer, multiple sclerosis, and T1D by capturing changes of immune cells over the course of a disease. This is a proof of concept study in mice.. so very early days. https://www.news-medical.net/news/20260204/Implantable-immune-scaffold-predicts-type-1-diabetes-weeks-before-symptoms.aspx XX A large global genetics study shows that many key drivers of Type 2 diabetes operate outside the bloodstream. In a major international project led in part by the University of Massachusetts Amherst and Helmholtz Munich in Germany, researchers linked hundreds of genes and proteins to the disease. The work, published in Nature Metabolism, points to a key challenge in diabetes research: the biology behind rising blood sugar does not play out the same way in every part of the body. It also shows why including people from many backgrounds matters, since genetic clues that stand out in one population may be faint or invisible in another. Huge study, 2.5 million people worldwide comparing patterns across seven tissues tied to diabetes and four global ancestry groups, then asked a simple question: what do you miss if you only measure blood? Across the seven tissues, the researchers found causal evidence pointing to 676 genes. Yet overlap with blood was limited: only 18% of genes with a causal effect in a primary diabetes tissue, such as the pancreas, showed a matching signal in blood. At the same time, 85% of genetic effects observed in diabetes-relevant tissues were completely absent from blood-based analyses. The findings lay out a roadmap for future research aimed at understanding the biological pathways underlying Type 2 diabetes and developing more effective treatments. https://scitechdaily.com/massive-global-study-rewrites-the-biology-of-type-2-diabetes/ XX Express Scripts settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated antitrust and consumer protection laws, and agreed to changes aimed at lowering costs for patients, insurers and small pharmacies The settlement, first reported by Reuters, fits with that goal, and allows the FTC to pare down a case brought by the former Biden administration against Cigna's Express Scripts, UnitedHealth Group Inc's (UNH.N), Optum unit and CVS Health Corp's (CVS.N), CVS Caremark. The case against Optum and Caremark is ongoing. Pharmacy benefit managers, which set how drugs are covered by health insurance, have faced a decade of scrutiny from regulators and lawmakers over pricing practices. While the industry has already made reforms, the settlement gives the FTC power to enforce broader changes at Express Scripts. The 10-year agreement restricts Express Scripts' ability to engage in practices critics say contribute to high costs, like pocketing rebate payments from drugmakers based on the list price of drugs. The FTC estimates the agreement could save patients as much as $7 billion over a decade. https://www.reuters.com/world/cigna-settles-ftc-insulin-case-commits-overhauling-drug-pricing-2026-02-04/ XX Audio? Congress has passed bipartisan legislation to extend and strengthen the Special Diabetes Program (SDP), a cornerstone of Federal investment in type 1 diabetes (T1D) research. The President signed the legislation and it is now law. Extends the SDP through December 31, 2026, and increases funding from $160 million to $200 million annually. Strengthens overall funding for the National Institutes of Health (NIH) by $415 million. Increases diabetes research funding at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) by $10 million. Created by Congress and administered by the NIH, the SDP has contributed nearly $3.6 billion to T1D research and has played a role in nearly every major breakthrough in the field. A recent study conducted by Avalere Health shows that of the nearly 3.6 billion invested into the SDP by Congress since the establishment of the program, the Federal Government has realized $50 billion in healthcare savings through improved health outcomes from the use of SDP driven therapies and devices https://www.breakthrought1d.org/news-and-updates/congress-passes-bipartisan-extension-of-the-special-diabetes-program-securing-critical-t1d-research-funding/ XX Dexcom is rolling out what they're calling AI-enabled enhancements to Stelo, further transforming how users track and understand their glucose health. Expanded Smart Food Logging including a comprehensive nutrition database of more than 1M meals that provides a breakdown of calories, carbohydrates, protein, fat, dietary fibers, and more. More ways to meal track including text search, barcode scanning or taking a photo of the meal, creating a seamless and intuitive meal tracking solution. A redesigned Daily Insights feature which will introduce a new interface with more personalized recommendations. The newest features will launch nationwide in the coming weeks.  XX Beta Bionics has received a warning letter from the Food and Drug Administration following an inspection last year, the company disclosed on Friday. The diabetes technology company said in a securities filing that the warning letter concerns non-conformities with the company's quality management system, medical device reporting, and correction and removals. The warning letter has not yet been posted by the FDA.   The company said in the filing that it has already taken actions to improve the processes described in the warning letter, and it is working on a written response to the FDA.   The firm does not expect the warning letter to affect the planned launch of a new insulin patch pump by the end of 2027. Beta Bionics unveiled a prototype of the device, called Mint, last year at the American Diabetes Association's Scientific Sessions. The company also does not expect the warning letter to affect its financial results. https://www.medtechdive.com/news/beta-bionics-receives-fda-warning-letter/811140/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue%3A+2026-02-04+MedTech+Dive+%5Bissue%3A81423%5D&utm_term=MedTech+Dive&fbclid=IwY2xjawPwhDZleHRuA2FlbQIxMABicmlkETFaUUcyYmNQWldjZ2xudElic3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHouF8M3IstTyslPRgeHWUWVVdOAGOtzPWt_yNFcj9eYruqSPz3e86Iwcbpt8_aem_7q4D97vJVjHKfEwvoyUpgw XX Sequel Med Tech is reviewing co-founder Dean Kamen's ties to Jeffrey Epstein after recently released documents revealed new details about the longstanding relationship between the two men. The documents show that Kamen visited Epstein's island, and remained in contact with him for years after Epstein was convicted of sex crimes involving minors. Kamen has not been accused of any wrongdoing. In a statement, Sequel Med Tech said the Manchester-based company is aware of the documents pertaining to Kamen and – quote - "Sequel's Board of Directors has unanimously decided to engage an external law firm to review these disclosures and provide recommendations aligned with our mission to serve people living with diabetes," Kamen has not issued a statement regarding his reported connection to Epstein.   https://www.bostonglobe.com/2026/02/04/metro/nh-dean-kamen-jeffrey-epstein-review/ https://www.bostonglobe.com/2026/02/04/metro/nh-dean-kamen-jeffrey-epstein-review/ https://www.nbcboston.com/news/local/nh-inventor-placed-on-leave-after-epstein-messages-surface-report-says/3888569/ XX Abbot reports 860 serious injuries linked to the recall of some of its glucose monitoring sensors. We told you about this recall late last year, these numbers are an FDA update.     Abbott said the sensors can provide incorrect glucose readings over extended periods, which could lead to users making dangerous treatment decisions, including eating excessive carbohydrates along with skipping or delaying insulin doses, potentially leading to serious health risks. The company said it has identified and resolved the cause of the issue, which relates to one production line among several that make Libre 3 and Libre 3 Plus sensors.   https://www.reuters.com/business/healthcare-pharmaceuticals/abbott-recalls-glucose-sensors-after-seven-deaths-linked-faulty-readings-2026-02-04/ XX Updates from Medtronic & Senseonics – and a first from Nick Jonas.. right after this..   I'm excited to share that the FDA has cleared the MiniMed 780G system with the Instinct sensor, made by Abbott, for people with type 2 diabetes.  Medicare has also now approved coverage for the Instinct sensor for use with the MiniMed 780G system. This clearance and expanded coverage mean more people will have access to pairing our most advanced automated insulin delivery technology with the Instinct sensor, that offers a smaller, 15-day sensor experience.  They're also launching the MiniMed 780G system Pump Evaluation Program.  This program gives individuals living with diabetes the ability to try the full MiniMed 780G system at no cost for 30 days.† This includes the pump, the sensor of their choice, one month of infusion sets and reservoirs, everything but the insulin. They'll contact your doctor for you to get a prescription and get the process rolling. https://www.medtronicdiabetes.com/pump-evaluation-program XX Senseonics announced today that its Eversense 365 continuous glucose monitor (CGM) system received CE mark approval – that's European clearance.  This comes on the heels of the launch of Eversense 365 with Sequel Med Tech's twiist pump, marking the first pump integration for the CGM. Senseonics plans to launch Eversense 365 in Germany, Italy, Spain and Sweden in the coming months. Meanwhile, Senseonics continues to work toward an FDA investigational device exemption (IDE) submission for its next-generation Gemini transmitter-less CGM by the end of this year. https://www.drugdeliverybusiness.com/senseonics-ce-mark-eversense-365-cgm/ XX A huge shout out to Dr. Emily Blum, who just accomplished riding 100 miles in Antarctica for Breakthrough T1D! Despite having no direct connection to Type 1 Diabetes, Emily has been riding and fundraising for BreakthroughT1D for 10 years now. She is an integral part of the Georgia Ride team, training and riding many miles, and most importantly has raised tens of thousands of dollars to support the cause of ridding the world of T1D. She is surgeon and deeply involved with medical innovation, with an incredibly busy schedule, but jumped at the chance to take on the challenge of riding a century on every continent. Having already completed North America, Europe, Australia, Asia, and now Antarctica, only Africa and South America remain. Emily rides on and continues to be an inspiration to everyone who meets her. XX   https://diabetes-connections.com/t1d-connection-and-people-magazine-elise-zach-share-their-story/ XX Nick Jonas's becomes the first artist ever to wear a CGM on an album cover - new upcoming solo album Sunday Best, releasing Feb. 6.  The release says: This marks a powerful step forward in normalizing diabetes and raising awareness for the condition on a global scale. This moment adds to the growing visibility of diabetes in pop culture, alongside milestones like a Type 1 diabetes Barbie and Pixar characters wearing diabetes technology.

A clinical conversation about the updated recommendations to enhance radiography safety in dentistry.  Special Guest: Dr. Erika Benavides  For more information, show notes and transcripts visit https://www.ada.org/podcast   Show Notes In this episode, we are having a clinical conversation about the updated recommendations to enhance radiography safety in dentistry.   We explore the major changes from previous guidelines, the rationale behind discontinuing patient shielding, the importance of patient‑centered imaging, and practical implications for dentists and academics.   Our guest is Dr. Erika Benavides, a Clinical Professor and Associate Chair of the Division of Oral Medicine, Oral Pathology and Radiology, and the Director of the CBCT Service at the University of Michigan, School of Dentistry. She is a Diplomate and Past President of the American Board of Oral and Maxillofacial Radiology (ABOMR). She also served as Councilor for Communications of the American Academy of Oral and Maxillofacial Radiology and Chair of the Research and Technology Committee. Dr. Benavides is a Fellow of the American College of Dentists and has published multiple peer-reviewed manuscripts in the multidisciplinary aspects of diagnostic imaging. She has been a co-investigator in NIH funded grants for the past 10 years and recently served as the Chair of the expert panel to update the 2012 ADA/FDA recommendations for dental radiography. Her clinical practice is dedicated to interpretation of 2D and 3D dentomaxillofacial imaging.    The two-part recommendations were updated by an expert panel which included radiologists, general and pediatric dentists, a public health specialist, and consultants from nearly every dental specialty.  Dr. Benavides shares some of the main takeaways and new updates is that that lead aprons and radiation collars are no longer recommended. This recommendation includes all dental maxillofacial imaging procedures and applies to most patients.  Also, a recommendation to avoid routine or convenience imaging, and focus instead of patient-centered imaging, based on the patients' specific needs. And, when possible, previous radiographs should be obtained.   Dr. Benavides shares that imaging must be patient‑specific, not protocol-driven, and encourages dentists to ask the following questions before dental imaging: "Do we need this additional information? Is this additional information going to change my diagnosis, or it's going to contribute to the diagnosis and treatment planning?"   The group discusses some of the possible challenges, and opportunities, to implement these new recommendations.    Resources:    This episode is brought to you by Dr. Jen Oral Care. Learn more about Dr. Jen.  Read the full clinical recommendations American Dental Association and American Academy of Oral and Maxillofacial Radiology patient selection for dental radiography and cone-beam computed tomography  Find more ADA resources on X-Rays and Radiographs.  Stay connected with the ADA on social media! Follow us on Facebook, Instagram, LinkedIn, and TikTok for the latest industry news, member perks and conversations shaping dentistry.  

Mary Beth Pfeiffer, the pioneering investigative journalist who transformed national understanding of Lyme disease, joins the Tick Boot Camp Podcast for a landmark conversation. Before her work, Lyme disease was widely dismissed as rare, mild, and easily treated. After her reporting, that narrative collapsed. Through her award-winning journalism and her groundbreaking book Lyme: The First Epidemic of Climate Change, she became the first major voice to expose the truth: Lyme disease is a global, climate-driven epidemic that is chronically misdiagnosed, dangerously underestimated, and systematically mishandled by mainstream medicine. In this interview, Mary Beth shares how her earlier investigative work on mental illness in U.S. jails prepared her to recognize patterns of institutional failure within the Lyme disease system. For decades, she documented how people with bipolar disorder and schizophrenia were misunderstood, punished, or dismissed by the very institutions meant to protect them. When she turned her attention to Lyme in 2012, she immediately recognized the same dynamic: patients with neurological and psychiatric manifestations were told they were anxious, depressed, or “crazy,” rather than infected. Families were blamed, symptoms were minimized, and children were left to suffer. Her background gave her a rare lens into how biological illness becomes mislabeled as psychological and how systems silence the very people who need help. Mary Beth explains how her investigative series for the Poughkeepsie Journal went viral worldwide, surprising even her editors. Her reporting was read in all 50 states and across Europe and Australia, prompting the CDC to contact her directly. She details what she uncovered through Freedom of Information Act requests, including internal emails between NIH and CDC officials referring to patients as “Lyme loonies” and framing the situation as a “war” against advocates. These documents revealed attitudes inside the highest levels of public health that shaped decades of policy, diagnostic guidelines, and patient care. The conversation dives into how a small group of early Lyme researchers defined the disease in the 1980s and then used their influence to control medical journals, shape NIH grant funding, and enforce rigid IDSA treatment guidelines. As Mary Beth explains, these early assumptions—often based on limited data and flawed antibody tests—became dogma. Their conclusions created an ecosystem where only short-course antibiotics were considered acceptable, chronic symptoms were dismissed, and doctors who treated beyond the guidelines were punished by medical boards. The result was a generation of patients abandoned by the system, forced to self-fund care, travel to distant specialists, and in many cases bankrupt themselves in search of answers. Mary Beth discusses how patients became her greatest teachers. She shares emotional stories, including children who lost years of their lives, athletes whose careers were derailed, and an 11-year-old boy misdiagnosed for so long he ended up in a hospital bed in his living room before finally being rescued by Dr. Charles Ray Jones. She describes support groups filled with people who had seen five, ten, or fifteen doctors and were told their symptoms were anxiety, depression, or “anything but Lyme.” The interview covers the scientific evidence supporting Lyme persistence, including animal studies, autopsy tissue findings, and molecular research showing Borrelia surviving standard treatment. Mary Beth explains why the two-tier antibody test has failed generations of patients, why indirect antibody tests are inherently flawed for immune-dysregulated populations, and why the future of accurate diagnosis depends on direct detection methods. She highlights emerging technologies, including promising work by Aces Diagnostics and Researcher Holly Ahern, which may finally offer accurate testing across all stages of infection. The conversation moves into the larger systemic problem: how money, insurance policies, medical boards, industry influence, and journal gatekeeping have shaped what doctors are allowed to do. Mary Beth and the Tick Boot Camp team explore why clinicians who try to help chronic Lyme patients often lose insurance coverage, face board complaints, or have their licenses threatened. They discuss how electronic monitoring, AI systems, and corporate-owned medical practices further restrict doctors from practicing individualized, patient-centered medicine. The second half of the interview focuses on the environmental drivers behind the explosion of Lyme disease. Mary Beth explains how warming temperatures, shorter winters, and ecological fragmentation have created ideal habitats for ticks. She describes how ticks have climbed mountains, expanded into higher latitudes, colonized suburban landscapes, and gained longer active seasons. These environmental changes, combined with human development patterns, have dramatically increased opportunities for exposure. She also addresses public interest in the bioweapons question raised by Chris Newby's book Bitten, explaining why historical documentation and FOIA evidence convinced her that military tick experiments occurred, even if their impact on today's epidemic is still unknown. The episode closes with Mary Beth's reflections on prevention, vigilance, and the psychological cost of losing the innocence of nature. She describes how she now sees fields, forests, and even yards differently and why she teaches her grandchildren to treat nature with both respect and caution. She shares her hope for the future: better diagnostics, more independent research, journalists willing to challenge medical orthodoxy, and a cultural shift that frees doctors to practice real medicine rather than rigid algorithms. This interview is essential listening for anyone affected by Lyme disease, anyone questioning why chronic illness is so often dismissed, and anyone seeking to understand how climate change, medical politics, and investigative journalism intersect in one of the most important health crises of our time.

The ability for gene editing exists, so how far is too far? The NIH announced the end of funding research on fetal tissue, a huge announcement! Two founding members of SALT (Science Alliance for Life and Technology), Dr. Lee and Dr. Sherley, join me with their reactions and insights on both issues. SALT (https://salt4life.org/)

Why does dementia look so different from one family to the next? This is a question I hear from caregivers all the time. Two people can have the same diagnosis and be the same age, yet their symptoms and caregiving challenges can look completely different. In this video, I break down what the 2025 NIH dementia progress report helps explain about why dementia does not follow one clear or predictable path. I cover what researchers are learning about dementia risk and protection, what is happening in the brain beyond memory loss, and what the science is showing about care planning and the caregiving experience. This is Part 2 of a two-part series based on the 2025 NIH dementia research update.  If you missed Part 1, you can find it here: https://youtu.be/Zzvdk5isef4 You can read the full NIH progress report here: https://www.nia.nih.gov/about/2025-nih-dementia-research-progress-report Get free weekly tools and tips in my newsletter, The Dementia Dose here: https://tinyurl.com/dementiadose-yt

In this episode, Kyle breaks down how A.W.F.U.L. women are trying to destroy the United States of America. Also, in the Quick Hitters segment, he discusses the killing of Alex Pretti, so-called “journalist” Don Lemon being arrested and indicted for assisting church protestors in Minnesota, the lawsuit alleging that the Christian camp Kanakuk covered up the sexual abuse of children for decades, support for gay people dropping in the US, the Left's wannabe Joe Rogan (Jennifer Welch) saying that “White Evangelical Christianity is a cancer”, the UK aborting itself to death, the NIH announcing it will no longer use tissue from aborted babies for research, the continued spiral of Baylor University away from Christianity, the latest moronic comments from Shane Claiborne, a grizzly murder just a few miles from his house, and much more. Let's get into it… Episode notes and links HERE. Donate to support our mission of equipping men to push back darkness. Learn more about your ad choices. Visit megaphone.fm/adchoices

View This Week's Show NotesStart Your 7-Day Trial to Mobility CoachJoin Our Free Weekly Newsletter: The AmbushIn this episode of The Ready State Podcast, we're joined by Dr. Kevin Hall—one of the world's leading metabolism researchers and a longtime NIH scientist—for a wide-ranging conversation on what the research actually says about weight loss, energy balance, and the modern food environment.Dr. Hall explains what we've learned from real-world and tightly controlled studies, including his work following The Biggest Loser contestants, and why exercise doesn't fully prevent the metabolic adaptations that can accompany major weight loss. We also unpack why “calories in, calories out” is both true in principle and often misunderstood in practice, how ultra-processed foods can drive overeating, and what GLP-1 medications may be changing in appetite biology.The episode also touches on Dr. Hall's departure from a 21-year career at the NIH, following the censorship of his team's findings on ultra-processed foods when they didn't align with preferred narratives—an experience he describes as chilling for scientific communication.Finally, we explore the practical challenges of doing high-quality nutrition research, why confident opinions can outpace the data, and what it will take to better understand—and ultimately prevent—diet-related chronic disease.What You'll Learn in This EpisodeWhy metabolism isn't “broken” — and why larger bodies burn more calories at restWhat the Biggest Loser study actually revealed about weight loss and regainWhy exercise doesn't “save” your metabolism during extreme dietingHow ultraprocessed foods change how much people eat — without acting like addictive drugsWhy calories in vs. calories is often misunderstood in practiceHow genetics and environment interact to shape body weightWhat GLP-1 drugs are really doing — and what they don't fixWhy nutrition science is underfunded, politicized, and desperately neededChapters(00:00) - Kevin Hall, PhD, Metabolism Researcher(01:01) - Dr. Hall on the Ready State Podcast(04:10) - Misconceptions About Metabolism(04:54) - The Biggest Loser Study & Metabolism Influence(13:09) - Challenges in Nutrition Research(19:10) - Metabolism's Role in Weight Loss(22:13) - Vitality Blueprint: Importance of Blood Work(25:45) - Calories In, Calories Out: Simplistic View?(30:45) - Understanding GLP-1 Agonists(32:20) - The Food Environment's Impact(36:05) - Ultra-Processed Foods and Caloric Intake(38:02) - The Complexity of Obesity(41:40) - Solutions for Our Food System(48:23) - Causes of Brain Fog(49:34) - Element: Nutritional Insights(51:39) - RFK Jr. Discussion(01:01:40) - Politics' Influence on Science(01:04:35) - Leaders in Nutrition Science(01:06:48) - Can Weight Loss Be Achieved?(01:08:10) - Universal Diets: Myth or Reality?(01:12:35) - Why Doritos Lead to Overeating(01:13:21) - Understanding Visceral Fat(01:14:04) - Momentous: Nutritional Products(01:20:25) - Book/TV Show/Music Recommendations(01:21:11) - Connecting with Dr. Hall(01:21:52) - OutroConnect with KevinWebsite | Bluesky | X | LinkedInBook: Food Intelligence: The Science of How Food Both Nourishes and Harms UsCheck out The Biggest Loser Study2019 Study: Ultra-Processed Diets Cause Excess Calorie Intake and Weight GainHuge thanks to our sponsors, Vitality, Momentous, and LMNT.

 - Tried for a home birth, midwives missed that my baby was breech, had an unplanned c-section- Incredible breastfeeding journey (SO thankful) that continues today, my daughter turned 2 - Realized when I was re-entering work and society that there was a major lack of nursing-access clothing that didn't *look* like nursingwear, I hated the chest zippers and extra flaps because I felt like they were obvious and distracting. - We prioritize natural fibers as a family, based on the research coming out of places like NIH and Mt. Sinai that connect synthetic fabrics with hormone disruption- Decided to build my own fashion brand that combined hormone-safe fabrics with nursing access dressesI'm the founder of Hone, hormone-safe apparel for postpartum moms in the nursing stage. FIND HER HERE:wearhone.comhttps://www.instagram.com/wear.hone/https://www.instagram.com/toni.toomey/PODCAST: https://www.instagram.com/thepostpartumstandard/

Today we have Dr. Francisco Gonzalez-Lima, a behavioral neuroscientist who was our guest in episodes 106 and 107 back in 2020. Since those 2020 interviews, Francisco and his colleagues at the Gonzalez-Lima Lab have produced dozens of more studies and papers that have advanced their work on methylene blue, transcranial lasers, memory enhancement, neuroprotection and neurocognitive disorders. Francisco and his lab at the University of Texas Austin are recognized as world leaders for their research on the relationships between brain energy metabolism, memory and neurobehavioral disorders. In today's interview, we talk to Francisco about his lab's most recent research on the beneficial neurocognitive and emotional effects of noninvasive human brain stimulation in healthy, aging and mentally ill populations. This research primarily uses transcranial infrared laser stimulation and multimodal imaging, which we will discuss in today's interview. Be sure to check out our earlier interviews with Francisco where he talked aobut his work on brain metabolic mapping and Alzheimer's, episode 106, and his research into methylene blue and near-infrared light as therapies for cognitive disorders, episode 107. Show notes: [00:04:32] Dawn and Ken open our interview with Francisco by mentioning that his lab has been very productive pursuing new research avenues since he was last on STEM-Talk. Ken mentions that Francisco has recently begun collaborating with his sister who has a PhD in computational and applied mathematics and asks Francisco to talk about the work they're doing together. [00:06:21] Dawn shifts to talk about the roadblocks that Francisco and his team have been dealing with, particularly that the review process for academic papers is unusually slow, not just for Francisco's team but at large. Dawn asks Francisco to discuss this issue. [00:10:37] Dawn recaps that in our previous interview with Francisco in 2020, the discussion focused on his research into methylene blue, which has been primarily used to treat methemoglobinemia, however, the potential for methylene blue to treat declining cognitive function is an active area of research. Despite Francisco's successful work with methylene blue, he often gets asked about its safety, largely due to various misconceptions. Dawn asks Francisco to talk about the misconceptions about methylene blue. [00:14:57] Ken asks if Francisco what some other misconceptions about methylene blue are. [00:20:43] Given the discussion of dosing, Ken asks Francisco what the safe dose range is for methylene blue in humans. [00:28:15] Ken mentions an article published a few months ago titled “Beyond plaques: How methylene blue and ketones address vascular hypometabolism in Alzheimer's disease” Ken goes on to mention that the article did a good job of summarizing Francisco's work as well as the work of Steve Cunnane, who was our guest on episode 59. Ken asks Francisco to discuss his thoughts on the article. [00:34:25] Dawn shifts focus to discuss Francisco's work on photobiomodulation, specifically transcranial infrared laser stimulation, which is a non-invasive method for neuroprotection and cognitive enhancement. Dawn explains that Francisco has written two chapters on this topic that summarizes his work in the area, one of which appeared in the Oxford handbook on transcranial stimulation, and the other is in a book on augmentation of brain function, based on a series of presentations he gave in Switzerland. Dawn asks Francisco to give a broad overview of his work on photobiomodulation and transcranial infrared laser stimulation. [00:43:52] Ken asks Francisco to talk about a paper titled “Light buckets and laser beams” that he and other researchers composed after attending a photobiomodulation workshop convened in 2023 by the director of the National Institute on Aging and several NIH lab directors. [00:51:25] Ken asks Francisco if there are any commercially available photobiomodulation devices that he thinks have substantial utility. [00:56:27] Ken asks Francisco to discuss mitochondrial disfunction in the context of neurodegeneration and his work on targeted stimulation of the mitochondria with photo biomodulation. [01:06:58] Ken asks Francisco to talk about the potential benefits of photobiomodulation on the aging process outside of neurodegenerative conditions. [01:17:16] Dawn mentions that transcranial infrared stimulation stimulates prefrontal energy metabolism and oxygenation, which produces cognitive enhancing effects. Dawn goes on to ask Francisco about his recent paper exploring this phenomenon in the context of depression titled “Augmenting internet based cognitive behavioral therapy for major depressive disorder with transcranial infrared laser stimulation.” [01:23:08] In light of the promising results of this study, Ken asks Francisco what he sees as the next research step to further this progress. [01:30:15] Ken comments on how Francisco has not only had great accomplishments in his recent research but also has a lot of fruitful opportunities ahead. [01:31:07] Ken asks Francisco if he has looked at photobiomodulation in combination with transcutaneous vagal nerve stimulation. [01:34:28] Ken mentions that for listeners interested in learning more about vagal nerve stimulation they can listen to episodes 179 with JP Erico, and 172 with Kevin Tracey. Francisco discusses the difficulty in knowing whether to attribute effects of vagus nerve stimulation to stimulation of the vagus nerve itself or incidental stimulation of the carotid artery … or some combination. [01:38:33] Ken mentions that Francisco is now trying to move away from animal studies and focus more on human studies. Ken asks what human trials he is hoping to conduct. [01:42:27] Dawn closes our interview thanking Francisco for once again joining us on STEM-Talk. Links: Gonzalez-Lima Lab Learn more about IHMC STEM-Talk homepage Ken Ford bio Ken Ford Wikipedia page Dawn Kernagis bio